University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
12-2012

The role of endogenous Bcl-xL in regulation of apoptotic signaling
pathways.
Colins Ogwandi Eno 1982University of Louisville

Follow this and additional works at: https://ir.library.louisville.edu/etd

Recommended Citation
Eno, Colins Ogwandi 1982-, "The role of endogenous Bcl-xL in regulation of apoptotic signaling pathways."
(2012). Electronic Theses and Dissertations. Paper 408.
https://doi.org/10.18297/etd/408

This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the
author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

THE ROLE OF ENDOGENOUS BcI-XL IN REGULATION OF APOPTOTIC
SIGNALING PATHWAYS

By

Col ins Ogwandi Eno
B.S., University of Buea, Cameroon, 2004
M.S., North Dakota State University, 2008
M.S., University of Louisville, 2010

A Dissertation
Submitted to the Graduate Faculty of the
University of Louisville School of Medicine
in Partial Fulfillment of the Requirements
for the Degree of

Doctor of Philosophy

Department of Pharmacology and Toxicology
University of Louisville
Louisville, Kentucky

December, 2012

Copyright 2012 by Colins Ogwandi Eno
All Rights Reserved

THE ROLE OF ENDOGENOUS BCL-xL IN REGULATION OF APOPTOTIC
SIGNALING PATHWAYS
By

Colins Ogwandi Eno

B.S., University of Buea, Cameroon, 2004
M.S., North Dakota State University, 2008
M.S., University of Louisville, 2010

A Dissertation Approved on

September 27, 2012

by the following Dissertation Committee:

Chi Li, Ph.D.

John W. Eaton, Ph.D.

Thomas Mitchell, Ph.D.

Brian Wattenberg, Ph.D.

J. Christopher States, Ph.D.

DEDICATION
This dissertation is dedicated to my dear brother, Dr. Robert Wundeh Eno, for his
unconditional love, encouragement, and financial and moral supports throughout
my studies. Growing up, although I knew I had the will power and determination
to pursue my education to the highest level, I knew my parents could not afford
the big dreams I had for myself. Brother Robert selflessly sacrifices everything he
had to ensure that I pursue and realize my dreams. He is the most altruistic
person I know and I will eternally be grateful to him. He is like the "father" I never
had, and each day I pray God gives him long life and blesses him abundantly.

III

ACKNOWLEDGEMENTS
First, I would like to thank the almighty God for giving me the strength, patience,
knowledge, determination, courage, confidence, good health and wisdom to
pursue and finish my dissertation. Although I am responsible for conceiving this
thesis research, this work would not have been completed without the support of
many individuals I met throughout the years. This dissertation would not be
complete without the support of my mentor, Dr. Chi Li. I am very thankful for his
support, trust and guidance, and for always pushing me to reach my full potential
almost to my breaking point. I am truly privileged to have worked with Dr. Li as
my mentor and will always be grateful to him for all of his encouragement and for
believing in me. My thanks are extended to my graduate committee members,
Drs. John W. Eaton, Thomas Mitchell, Brian Wattenberg and J. Christopher
States, for their critical and insightful comments and suggestions. I would also
like to extend my thanks to the past and present members of Chi U's Laboratory
including Kristen Olberding, Drs. Yanglong Zhu, Xiaoli Wang, and Guoping Zhao
for their support, suggestions and constructive criticisms.

I am grateful to Dr. On no Kranenberg at the University Medical Center Utrecht,
Netherlands for providing shNoxa HCT116 cell lines, Dr. Joseph Opferman at St.
Jude Children's Research Hospital, Memphis, TN, for providing Mcl-1-KO MEFs,
Professor Andreas Strasser at the Walter and Eliza Hall Institute of Medical

iv

Research, Parkville, VIC, Australia for providing Noxa-KO MEFs, Sabine Waigel,
Yinlu Chen and Vennila Arumugam at the University of Louisville Microarray
facility for microarray experiments, Christopher Worth at the University of
Louisville Brown Cancer Center Flow Cytometry Laboratory for cell sorting, and
Dr. Carl White at the Rosalind Franklin University of Medicine and Science, North
Chicago for providing Ca 2+ data. This work was supported by NIH grants
CA106599, RR018733 and funding from Brown Cancer Center (CL). I am also
very thankful to the Integrated Programs in Biomedical Sciences (IPIBS) for
providing funding for my first two years of graduate studies, the department of
Pharmacology and Toxicology for their intense training, and the School of
Interdisciplinary and Graduate Studies (SIGS) for providing me with a one year
dissertation completion award. I am thankful to the American Society of
Pharmacology and Experimental Therapeutics (ASPET), the University of
Louisville (UofL) School of Medicine (SOM), UofL Graduate Student Council
(GSC), and the National Institutes of Health (NIH) National Graduate Student
Research Conference for providing me with travel awards to present my work at
national conferences.

I want to thank my wife, Traicy Awaiwing Eno nee Itambi, for her endurance,
moral support, patience, encouragement and understanding especially for all the
long hours I spent in the laboratory. I am equally thankful to my entire family for
their moral, spiritual and financial support. I am especially thankful to my siblings,
Dr. Robert Eno, Julius Eno, Alice Eno, Cyprain Eno, Divina Eno and Binda

v

Gilbert, and my mom, Mrs. Elizabeth Enow, for their unconditional love. Special
thanks to all of my nieces and nephews (Wundeh, Abanda, Brandon, Rhema,
Prince, Blesse, Awaiwing Eliza, Tetris, Elmira, Awiawing Ambumban, Wilma,
Janelle and Tiana) for their adorable smiles. I can never thank them enough. I
am also indebted to other family members whom made it possible in one way or
another for me to achieve my goals including Dr. and Mrs. Pascal Binda, Mrs.
Ngwi Eno, Akwi Lilian, Godlove Binda, Glory Ambang Abah, Vallerie Kabba,
Simon Abah, Itambi Jessy and Drs. Itambi Cletus and Maxwell Asoh Itambi. I
also recognize the moral support of my very good friends including TAO,
Efangafa, Bolima, Fortty, Franco, Sahidu, Itambi Collins, Waponcho, Drs.
Mongoh and Enoru, and the Cameroonian students here at the University of
Louisville health science center both past and present for their input.

Last but not least, I want to thank Prof. and Mrs. Tafah Edokat and Mr. and Mrs.
Itambi Zachariah, for all of their moral, spiritual and financial support.

vi

ABSTRACT
THE ROLE OF ENDOGENOUS BCl-XL IN REGULATION OF APOPTOTIC
SIGNALING PATHWAYS

Colins Ogwandi Eno
September 27, 2012
Bcl-2 proteins are major regulators of cellular responses to various apoptotic
stimuli. Among them, overexpression of the anti-apoptotic BcI-2 protein Bcl-xL
modulates

organelle-specific

apoptotic

pathways.

To

understand

the

mechanisms by which endogenous BcI-XL regulates apoptosis, mouse embryonic
fibroblasts (MEFs) deficient in Bcl-XL expression (Bcl-x-KO) was generated.
Studies of Bcl-xL exclusively targeted to an organelle in Bcl-x-KO MEFs indicate
that the mitochondria- and ER-Iocalized Bcl-xL play distinct roles in apoptosis
resistance and Ca 2+ homeostasis. Specifically, mitochondrial BcI-XL can regulate
apoptosis independently of ER Bcl-XL, and when localized exclusively at the ER,
BcI-XL impinges on Ca 2+ homeostasis but does not affect apoptosis unless Bcl-xL
is present in additional cellular compartments. Furthermore, I investigated how
Bcl-2 proteins, especially Bcl-xL, might regulate oxidative stress-induced
apoptosis. My studies reveal a signaling pathway, in which the oxidative stress
inducer hydrogen peroxide (H202) activates Noxa, leading to a decrease in Mcl-1
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expression levels and subsequent increase in apoptosis in the absence of BcI-xL
expression.

Finally,

I studied the exact roles of lysosomal membrane

permeabilization in apoptosis cascade triggered by oxidative stress and how
LMP is regulated by the complex Bcl-2 protein network. My studies elucidate a
novel molecular mechanism that couples lysosomal membrane permeabilization
with mitochondrial membrane permeabilization and ultimate cell death during
oxidative stress-induced apoptosis.

viii

TABLE OF CONTENTS
PAGE
DEDICATION ...................................................................................................... iii
ACKNOWLEDGEMENTS ... .................................................................................. iv
ABSTRACT ......................................................................................................... vii
liST OF FIGURES ............................................................................................... xi
liST OF TABLE ........... ....................................................................................... xiv

CHAPTER I: GENERAL INTRODUCTION .................................................... 1
Programmed cell death (Apoptosis) ................................................ 1
Biological significance of apoptosis ................................................. 5
Pathways of apoptosis ................................................................ 10
Regulation of apoptosis ................................................................ 17
Hypothesis and significance of the projects ................................. 30

CHAPTER II: DISTINCT ROLES OF MITOCHONDRIA- AND ER-lOCALIZED
BCl-XL IN REGULATION OF APOPTOSIS AND Ca 2+
HOMEOSTASIS .......................................................................... 33

Introduction ................................................................................. 33
Materials and Methods ................................................................. 36
Results ......................................................................................... 47

ix

Discussion ......................................................... ,.......................... 74
CHAPTER III: ENDOGENOUS BCl-XL MODULATES CEllULAR RESPONSE
TO OXIDATIVE STRESS-INDUCED APOPTOSIS ................... 78

Introduction ................................................................................. 78
Materials and Methods ................................................................. 80
Results ......................................................................................... 87
Discussion ............................................. ..................................... 112
CHAPTER IV: THE IMPORTANT ROLE OF lYSOSOMAL MEMBRANE
PERMEABILIZATION DURING OXIDATIVE STRESSINDUCED APOPTOSIS ......................................................... 118

Introduction ............................................................................... 118
Materials and Methods ............................................................... 121
Results ................................................... .................................... 128
Discussion .................................................................................. 152
CHAPTER V: CONCLUSION AND FUTURE DIRECTIONS ........................... 157
REFERENCES ................................................................................................. 161
APPENDIX: List of abbreviations ...................................................................... 175
CURRICULUM ViTAE ...................................................................................... 178

x

LIST OF FIGURES
PAGE
1.1

Morphological differences between cells during apoptosis and necrosis ...... 4

1.2 Apoptosis is important for proper development ............................................ 7
1.3 The intrinsic (mitochondria) pathway of apoptosis ...................................... 11
1.4 The extrinsic (death receptor) pathway of apoptosis .................................. 13
1.5 The mixed pathway of apoptosis ................................................................ 15
1.6 Activation of outer mitochondrial membrane permeabilization by Bcl-2
protein family .............................................................................................. 28
2.1

Generation of wild type and Bcl-x-KO MEFs .............................................. 39

2.2 bc/-x deficiency does not cause compensatory changes in expression

of other Bcl-2 proteins ................................................................................. 51
2.3 Endogenous Bcl-xL modulates cellular response to different apoptotic
stimuli ......................................................................................................... 53

2.4 Reexpression of BcI-xL in Bcl-x-KO MEFs restores its resistance to
apoptotic stimuli in a BcI-XL dose-dependent manner ................................. 56
2.5 Generation of mitochondrial- and ER-targeted BcI-xL mutants ................... 60
2.6 Mitochondrially targeted BcI-xL inhibits apoptosis more efficiently than
BcI-xL targeted to the ER ........................................................................... 63
2.7 ER-Iocalized BcI-xL but not mitochondrially targeted Bcl-xL modulates
ER Ca 2 + homeostasis ............................................................................... 68

XI

2.8 Anti-apoptotic activities of ER-targeted Bcl-XL depends on endogenous
Bcl-xL ..................................................................................................... 71-72

3.1

Endogenous Bcl-xL inhibits H20 2-induced apoptosis in a dose dependent
manner ...................................................................................................... 89

3.2 Expression levels of pro-apoptotic BH3-only Bcl-2 proteins in MEFs ......... 92
3.3 Endogenous BcI-xL most effectively inhibits Noxa-induced apoptosis ........ 94
3.4 Expression of BcI-XL in Bcl-x-KO MEFs restores their ability to prevent
BH3-only Bcl-2 proteins-induced apoptosis ............................................... 95
3.5 H20 2 induces Noxa expression ................................................................... 98
3.6 H202-induced apoptosis is mediated by Noxa .......................................... 101
3.7 Mcl-1 expression reduction in response to H202 depends on Noxa but
not Bcl-xL ................................................................................................ 103
3.8 Mcl-1 overexpression inhibits H202-induced apoptosis ............................ 106
3.9 Reduction in BcI-xL and Mcl-1 expression simultaneously induces
spontaneous apoptosis ............................................................................. 110
3.10 Bcl-2 proteins coordinately regulate H202-induced apoptosis .................. 117
4.1

H20 2 induced Noxa-independent LMP ...................................................... 130

4.2 Mitochondria membrane permeabilization is dependent on Noxa
expression ................................................................................................ 134
4.3 Stabilizing lysosomal membrane by DFO inhibits Noxa-dependent
apoptosis induced by H202 ...................................................................... 138
4.4 DFO fails to prevent apoptosis induced by other apoptotic stimuli .... 142-143
4.5 DFO does not prevent apoptosis induced by ectopic Noxa expression .... 146
4.6 H202-induced increase in Noxa expression is specifically mediated
by lysosomal membrane permeabilization ............................................... 148
xii

4.7 Exogenous iron specifically increases Noxa expression .......................... 151
4.8 Oxidative stress-induced LMP promotes Noxa-dependent apoptosis ...... 156

XIII

LIST OF TABLE
PAGE

2.1 Changes in mRNA expression of Bcl-2 genes induced by bc/-x
deficiency were determined by microarray analysis ................................... 43

xiv

CHAPTER I
GENERAL INTRODUCTION

1.1. Programmed cell death (Apoptosis)
The word apoptosis is coined from Greek origin meaning "dropping off or falling
off," and it is taken from the process by which leaves fall from trees or petals from
flowers. Apoptosis is a biological process by which all multicellular organisms
selectively eliminate damaged, infected, unwanted, or potentially neoplastic cells
from the body [1-3]. It involves a programmed sequence of events ultimately
resulting in the elimination of cells and/or cell debris. Apoptosis is one of the most
common mechanisms by which the body eliminates damaged cells without local
inflammation from leakage of cellular contents. Cell contents are eliminated from
the body by phagocytic macrophages [4]. Apoptosis plays critical role in normal
development, disease progression, and maintenance of tissue homeostasis, and
serves as a defense strategy against the emergence of cancer [5]. Apoptosis is
usually under stringent genetic control and can be activated by stimuli from
multiple sources.

Apoptosis occurs through a series of biochemical events which cause a large
number of morphological changes in the cells including shrinking of the cells,
blebbing of membrane, condensation and fragmentation of the nuclear material,
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and formation of apoptotic bodies. In apoptotic cells, the membrane phospholipid
phosphatidyl serine (PS), which is normally localized on the cytosolic side of cell
membrane, becomes exposed on the extracellular side of the cell. The
mitochondrial membrane breaks open with the release of apoptogenic proteins
including cytochrome c and Diablo/Smac from the inter-membrane space (IMS)
of the mitochondria to the cytosol ultimately leading to cell death [4, 6, 7].
Apoptosis is initiated in response to certain developmental signals or in the
presence of various stimuli including deprivation of essential growth factors,
binding of ligand receptors such as tumor necrosis factor receptors (TNFR) on
cell surfaces, DNA damage, loss of cellular attachment, decrease in local
concentration of tissue morphogens, or major changes in homeostatic state of
the cell [3, 8].

Another form of cell death is known as necrosis. Cell death by necrosis differs
from cell death by apoptosis, and it can be the result of injury, excessive stress or
extreme exposure to intolerable physiological conditions including heat, toxins,
hypothermia, mechanical trauma or hypoxia [9-11]. Morphological changes in
cells undergoing necrosis include cell swelling, cell rupture, chromatin digestion,
and disruption of organelle membranes such as the mitochondrial membrane
(Figure 1.1) [11]. As a result, cell contents are released into surrounding tissues
where they cause cellular and nuclear lysis, leading to an inflammatory response
[11, 12]. Inflammatory response is not present in apoptotic cell death because
cell debris and apoptotic bodies are removed by phagocytic macrophages.
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Necrosis is almost always detrimental and can be fatal to the organism, whereas
apoptosis is a natural cellular process that can either be detrimental or provide
some beneficial effects to the organism.

Dysregulation of apoptosis is implicated in the development of many disease
states such as cancers and neurodegenerative diseases including Alzheimer's,
Huntington's and Parkinson's diseases [13-15]. Excess or limited apoptosis can
disrupt tissue homeostasis of multicellular organisms. If apoptosis occurs more
than

cell

proliferation,

neurodegenerative diseases will

be exacerbated.

Insufficient apoptosis on the other hand can accelerate cancer development [7,
15]. Therefore, maintaining a balance between apoptosis and cell proliferation is
critical for the well-being of all multicellular organisms.
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Figure 1.1. Morphological changes in cells during apoptosis and necrosis
[11 ].
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1.2. Biological significance of apoptosis
1.2.1. Proper development
Since the 1930s, apoptosis has been recognized as an important process in
development. The involvement of apoptosis in development has been well
studied in three organisms: nematodes (Caenorhabditis elegans), fruit flies
(Drosophila melanogaster) and mouse (Mus musculus). In C. elegans, during

embryogenesis and soon after cell division, development of the hermaphrodite
involves cell death of approximately 131 of the 1090 somatic cells through
apoptosis [16]. In D. melanogaster, apoptosis is critical for the completion of
development, and studies have shown that developmental disorders and/or
death may occur once apoptosis is inhibited [5, 17].

During the early stages of development in the mammalian nervous system, about
50% of neurons undergo apoptosis [18]. The formation of synapses between
neurons in brain and spinal cord also requires the elimination of excess cells by
apoptosis. During nerve cell development and attachment to their target cells and
organs, more nerve cells are generated than their target cells. Excess nerve cells
are eliminated by apoptosis to adjust the number of nerve cells to the size of
target organ(s), thereby matching the number of developing nerve cells to the
number of target cells and organs. During embryonic development, apoptosis
helps to remodel tissues, sculpture the body, shape the organs, and carve out
the fingers and toes. For instance, formation of proper fingers and toes in the
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fetus requires removal of tissues between them by apoptosis. In this process,
massive apoptosis occurs between the digits (fingers and toes), resulting in the
separation of the digits (Figure 1.2A). Without sufficient apoptosis, the digits
remain joined by soft tissues as seen in the duck hind limbs (Figure 1.28) [19].
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Figure 1.2. Apoptosis is important for proper development. (A) Cells
between the digits undergo apoptosis to generate proper fingers and toes.
(8) Insufficient apoptosis cause the cells in digits to remain joined by soft
tissues as seen in the duck hind limbs [19] .
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1.2.2. Maintenance of tissue homeostasis
In an average human adult, billions of cells die every day due to apoptosis. Dead
cells are constantly replaced with new cells originating from the body's stem cell
populations [20]. Normal tissue homeostasis or constant internal environment is
regulated by apoptosis. In a healthy organism, the rate of cell proliferation is
approximately the same as the rate of apoptosis. This balance in apoptotic state
is critical for the well-being of all multicellular organisms. If cells die more than
they are being replaced, disease conditions such as neurodegeneration will be
accelerated. On the other hand, insufficient apoptosis can result in cancer
development [21]. Millions of Band T cells are generated daily in the immune
system. The majority of these cells (> 95 %) die during maturation by apoptosis.
Deletion of expanded effector T cells during immune responses, preservation of
T cell memory and general homeostasis of immune cells are caused by
apoptosis.

1.2.3. Elimination of unwanted cells
Abnormal cells, cells with

unrepaired damaged DNA, and/or potentially

neoplastic cells are eliminated from the body by apoptosis. Cells respond to DNA
damage in one of three ways: (i) damaged DNA is either repaired by the cell's
DNA repair machinery and cells resume their normal activity; (ii) damaged DNA
can guide dividing cells into cell cycle arrest. Cell division stops until the
damaged DNA is either repaired or destroyed. Cells resume normal cell cycle
only when the damaged DNA is repaired; (iii) finally, if the damage to the DNA is
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too severe to be repaired, cells are forced to undergo apoptosis. DNA damage in
cells can disrupt proper embryonic development that induces severe teratogenic
and mutagenic effects leading to development of many cancers [22, 23]. Cells
therefore have developed protective defensive machinery to detect and repair
damaged DNA or trigger apoptosis. In response to DNA damage, cells activate
the genomic guardian protein p53 [24-26]. As a potent inducer of apoptosis, p53
triggers apoptosis to eliminate the cells with irreparable DNA damage from the
body. Most cancer cells often have defective p53 proteins which allow them to
evade apoptosis and proliferate uncontrollably.

Apoptosis also plays an important role in elimination of cells that pose threats to
the organism. For example, self-reactive cells of the immune system and virally
infected cytotoxic T cells are eliminated from the body by apoptosis [27].
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1.3. Pathways of apoptosis

Apoptosis generally occurs through one of three signaling pathways, including
the mitochondrial (intrinsic), the death receptor (extrinsic), and the mixed
pathways.

1.3.1. Intrinsic (mitochondrial) pathway of apoptosis

Death stimuli generated from within the cell activate the intrinsic pathway of
apoptosis. In the presence of death stimuli, signals are translocated to the
mitochondria where they activate the pro-apoptotic 8c1-2 proteins, resulting in
formation of permeation channels on the outer mitochondrial membrane (OMM)
through which apoptogenic proteins including cytochrome c and Diablo/Smac
leave the mitochondrial inter membrane space (IMS) and enter the cytosol. While
in the cytosol, cytochrome c and Diablo/Smac activate a cascade of caspase
reactions ultimately leading to apoptosis [28, 29]. Cytochrome c activates the
apoptotic protease activating factor 1 (apaf-1), which in turn promotes the
transition of the inactive forms of caspases (zymogen, pro-caspases) to their
active counterparts (caspases), while Diablo/Smac directly interacts with
inhibitors of apoptosis proteins (lAPs) and disrupts their ability to inactivate
caspases, thereby promoting apoptosis (Figure 1.3) [30, 31].

10

GENOTOXINS

l
Nucleus

Puma/Noxa

11-

BcI-2IBcl-xL Bcl-2 protein family

Bax/Bak

~

lAPs

Caspase cascade
Caspase 3, 6, 7

~

Apoptosis

Figure 1.3. The intrinsic (mitochondrial) pathway of apoptosis. In the
presence of apoptotic stimuli such as DNA damage, p53 is activated .
Activated p53 then activates pro-apoptotic 8c1-2 protein members which
interact on the OMM to form permeation channels which allow cytochrome
C and Diablo/Smac to leave the mitochondria and enter the cytosol. In the
cytosol , cytochrome c then initiates a caspase cascade ultimately leading
to apoptosis, while Diablo/Smac interacts with lAPs and disrupts their
ability to inhibit caspases thereby also leading to apoptosis.
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1.3.2. Extrinsic (death receptor) pathway of apoptosis

Unlike the intrinsic pathway of apoptosis where death signals are initiated from
within the cell, death signals for extrinsic pathways of apoptosis are initiated from
outside the cell. Activation of extrinsic pathways of apoptosis does not involve the
mitochondria, interactions of the Bcl-2 proteins or release of cytochrome c from
the mitochondrial IMS to the cytosol. Here, specific death ligands such as tumor
necrosis factor (TNF), Fas Ligand (FasL) or TNF-related apoptosis-inducing
ligand (TRAIL) bind to their respective specific transmembrane death receptors
including Fas, tumor necrosis factor receptor 1(TNFR1), p75, DR4 [32].

Binding of death ligands to their respective death receptor promotes the
clustering and recruitment of the adaptor protein Fas-associated death domain
(FADD) and the inactive forms of the initiator caspases 8 and 10 (pro-caspases 8
or 10), thereby forming the death-inducing signaling complex (DISC). Therefore,
the DISC is made up of the FADD, caspase 8 and caspase 10. The DISC brings
the pro-caspase molecules in close proximity, ensuring access for their
autocatalysis and release into the cytosol [33-37].

Caspase 8 or 10 then

activates the effector caspases 3/6/7 in a caspase cascade reaction leading to
apoptosis (Figure 1.4).
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Figure 1.4. The extrinsic (death receptor) pathway of apoptosis. Extrinsic
apoptotic signaling pathway is generated from outside the cell. Initiation of
apoptosis results in binding of death ligands to specific transmembrane
death receptors , which causes clustering and recruitment of the adaptor
molecule FADD , procaspase 8, 10 to form the DISC , subsequently
activating-caspase 8, 10. Caspase 8, 10 then activates caspase 3/6/7
ultimately leading to apoptosis .
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1.3.3. The mixed pathway of apoptosis
While activation of apoptosis in most cells can be initiated either from within the
cell (intrinsic) or outside the cell (extrinsic), there are certain instances where
induction of apoptotic signaling pathways from external sources can also lead to
activation of both intrinsic and extrinsic apoptotic pathways (mixed pathway). In
this paradigm, death stimuli generated from outside the cell cause activation of
pro caspase 8, pro caspase10, and formation of the DISC in a similar fashion as
observed with the extrinsic pathways. The formation of the DISC will ultimately
lead to autocatalysis and activation of caspase 8 and 10 [33-37].

Activated caspase 8 can enter one of two routes: (i) it can activate the effector
caspases 3, 6 and 7, leading to apoptosis as in the extrinsic pathway or (ii) it can
enter the intrinsic pathway of apoptosis by interacting with the BcI-2 family of
proteins. In this case, caspase 8 cleaves the inactive pro-apoptotic BH3-only
protein Bid into its truncated (activated) form (tBid). The tBid then activates the
BcI-2 proteins Bax and Bak at the OMM. Bak and Bax undergo conformational
changes and oligomerize resulting in formation of permeation pores on the OMM.
Cytochrome c and Diablo/Smac then are released from the mitochondrial IMS
into the cytosol where they exert their pro-apoptotic effects in the same fashion
as they do in the intrinsic apoptotic signaling pathways
Figure 1.5.
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Figure 1.5. The mixed pathway of apoptosis. Stimuli from extracellular

sources lead to DISC formation and activation of caspases 8 and 10.
Activated caspase 8 and 10 can either cleave effector caspases to cause
cell death (as with the extrinsic pathway) or can enter the intrinsic pathway
by interacting with the Bcl-2 family of proteins. Caspase 8 converts fulllength Bid into tBid which then interacts with Bax!Bak inducing their
oligomerization and formation of permeation pores on the OMM, allowing
apoptogenic proteins such as cytochrome c and Diablo! Smac from the
mitochondria into the cytosol where they exert their effects.
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1.4. Regulation of apoptosis
Apoptosis is primarily regulated by the caspases and the Bcl-2 family of proteins.

1.4.1. Caspases
Caspases are a group of cysteine proteases which cleave proteins at sites
proximal to aspartic acid residues [38]. Caspase activation usually is considered
the molecular hallmark of apoptosis [39]. Caspases exist in their inactive forms
(pro-caspase), and are activated during apoptosis by pro-apoptotic proteins [40].
To date about 12 caspases have been identified, but not all caspases are
involved in regulation of apoptosis. For instance, caspase 1 is critical for the
regulation of the biological processes irrelevant to cell death including maturation
of red blood cells and skeletal muscle myoblasts, while caspase 14 is essential in
skin cell development [41].

Two classes of caspases involved in apoptosis are the initiator (apical) and the
effector (executioner) caspases. Initiator caspases, including caspases 2, 8, 9
and 10, are activated in response to upstream apoptotic stimuli. Initiator
caspases cleave and process the effector caspases 3, 6 and 7. Once activated,
effector caspases are responsible for triggering cell death by degrading key
structural proteins within cells.

17

1.4.2. The Bcl-2 proteins
The BcI-2 family of proteins is one of the major regulators of the intrinsic pathway
of apoptosis. They derived their name from B-cell/ymphoma//eukemia 2, as the
second member of a range of proteins initially discovered during chromosomal
translocations involving chromosomes 14 and 18 in human follicular lymphomas
[42]. BcI-2 is the founding members of the Bcl-2 family of proteins and is encoded
by Bcl-2 gene [43]. To date, approximately 20 different members of the Bcl-2
protein family have been identified. Members of the Bcl-2 family of proteins all
share one to four homologous BcI-2 homology (BH) domains important for homoand hetero-dimeric interactions among different family members. Bcl-2 proteins
can be pro-apoptotic or anti-apoptotic [3, 44, 45] based on the number of BH
domains and their ability to regulate apoptosis [46].

1.4.2.1. The pro-apoptotic Bcl-2 proteins
The pro-apoptotic BcI-2 proteins are critical for the initiation and or activation of
the intrinsic pathway of apoptosis. They are divided into two structurally and
functionally distinct categories: multidomain and BH3-only Bcl-2 proteins [47].

1.4.2.1.1. The multidomain pro-apoptotic Bcl-2 proteins
The multidomain pro-apoptotic BcI-2 proteins Bax, Bak and Bok share three BH
domains (BH1-BH3). They are responsible for forming permeation channels on
the OMM, which in turn disrupt mitochondrial membrane integrity during
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apoptosis thus allowing the

release of apoptogenic proteins from

the

mitochondria to the cytosol. While Bax and Bak are ubiquitously present in all
tissues, Bok is expressed only in reproductive cells [48]. In healthy cells, Bax and
Bak are localized in different subcellular compartments. Bak is constitutively
integrated in the OMM, while Bax is localized in the cytosol. The carboxylterminal membrane-anchoring region of Bax is normally sequestered into its
hydrophobic pocket keeping Bax constitutively inactive in the cytosol [49). But in
the presence of death stimuli, Bax undergoes conformational changes at both the
amino- and carboxyl- termini, leading to its translocation to the OMM and
eventual formation of large oligomeric complexes [50, 51]. Since Bak resides
solely in the mitochondria, in the presence of apoptotic stimuli Bak changes
conformation and forms oligomeric complexes as well [52). Oligomeric Bax and
Bak form permeation channels on OMM to facilitate the release of cytochrome c
and Smac/Diablo from mitochondrial IMS to the cytosol where they carry out their
pro-apoptotic functions.

Bax can also be activated in ER during apoptosis [53]. Studies have shown that
most mice deficient in both Bax and Bak (double knockout, DKO) die during
embryonic stages, but the few that survive to adulthood have an accumulation of
excessive cells in various tissues [54]. Cells from Bax and Bak DKO mice are
highly resistant to apoptosis induced by all stimuli triggering the mitochondrial
signaling apoptotic pathway [54]. Activation of Bax and Bak proteins are
therefore critical for the initiation of apoptosis in mammalian cells.

19

1.4.2.1.2. The pro-apoptotic BH3-only Bcl-2 proteins
The pro-apoptotic BH3-only Bcl-2 proteins, including Noxa, tBid, Puma, Bim,
Bmf, Bik, Nix, Bnip3, Bad, and Hrk, all have only a single BH3 domain in
common [6]. The BH3 domain is an interactive domain that is necessary and
sufficient for the killing action of BH3-only Bcl-2 proteins. They are activated by
many diverse apoptotic stimuli, including deprivation of essential growth factor,
cell-cell or cell-matrix interactions, ER stress, exposure to physical or chemical
DNA damaging agents, viruses, bacteria, or TNF-like cytokines via transcriptional
upregulation, changes in subcellular localization, altered protein stability or posttranslational modifications. Not all BH3-only BcI-2 proteins are activated by a
single apoptotic stimulus. They are always under stringent control at the
transcriptional and post-translational levels [6].

1.4.2.1.2.1. Transcriptional and post-translational regulation of BH3-only
Bcl-2 proteins

As mentioned earlier, the BH3-only BcI-2 proteins are under strict transcriptional
and/or post-translational control. Different BH3-only Bcl-2 proteins are activated
by various stimuli through different mechanisms, depending on the cell type and
the type of stimuli present. The BH3-only Bcl-2 proteins Puma, Noxa, Bim and
Hrk are subject to stringent transcriptional control, whereas the rest of the other
BH3-only Bcl-2 proteins are mostly activated by post-translational modification.
Both Noxa and Puma are activated by the tumor suppressor protein p53 usually
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in the presence of apoptotic stimuli that generate stress to the cell such as DNA
damage [55, 56]. DNA damage causes p53 activation subsequently increasing
Noxa and Puma mRNA and protein expression in thymocytes and fibroblasts [55,
56]. Transcriptional control of Bim is much more complex and different from that
of Puma and Noxa. Withdrawal of essential growth factors cause increased
expression of Bim in both neuronal [57] and hematopoietic cells [58]. Bim
expression is also induced transcriptionally by ER stress through the transcription
factor CHOP [59]. In apoptotic cells Bim is stabilized by JNK, and in healthy cells
it is destabilized by Erk1/2 [60, 61]. Hrk is induced during embryogenesis in
neuronal tissues containing relatively large number of apoptotic cells including
the trigeminal and dorsal root ganglia, and the anterior horn of the spinal cord
[62]. In murine myeloid and lymphoid progenitor cells, withdrawal of essential
growth factor induces Hrk expression sufficient to trigger apoptosis [63]. Hrk is
also activated transcriptionally by stress activated/c-jun N-terminal kinase
(SAPKlJNK) [64, 65].

Other BH3-only BcI-2 proteins, including Bad, Bik, Bid, Bim and Bmf, are
regulated by post-translational modification, which makes them active and
available to interact with other proteins. Bad is activated by dephosphorylation
and deactivated by phosphorylation. Bad is deactivated by phosphorylation at
several serine residues (S-112, S-136 and S-155) by kinases including AKT,
protein kinase A (PKA), and Raf-1[66-68]. In cells undergoing apoptosis, Bad is
dephosphorylated by the phosphatases protein phosphatase 2A (PP2A) or
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calcineurin

[69].

Like Bad,

Bik is also modified

post-translationally by

phosphorylation. However, phosphorylation of Bik by casein kinase II or related
enzymes activates Bik protein [70]. In contrast to Bad and Bik, Bid is activated by
a different post-translational modification mechanism. In healthy cells, inactive
full-length Bid is localized in the cytosol. In the presence of apoptotic insults, Bid
is processed by caspase 8 into its truncated fragment, tBid [71]. The tBid is then
translocated to the mitochondria where it interacts with pro-apoptotic multidomain
Bcl-2 proteins including Bax and Bak to exert its pro-apoptotic activities.

In addition to transcriptional activation, Bim is also activated post-translationally.
Bim and Bmf are two BH3-only BcI-2 proteins regulated by sequestration of
cytoskeleton structure inside cells [72]. In healthy cells, Bim is sequestered to the
microtubule dynein motor complex through its interaction with Dynein Light Chain
1 (DLC1/LC8) [72]. Bmf is sequestered to the actin cytoskeleton-based myosin V
motor complex through its interaction with dynein light chain. In response to
stress stimuli such as detachment of cells from the substratum (anoikis) or drugs
that depolymerize actin, Bmf is released to trigger apoptotic signaling.

The different pro-apoptotic BH3-only BcI-2 proteins are activated based on the
type of stress to the cell. The BH3-only BcI-2 proteins interact with either antiapoptotic members (Bcl-XL, BcI-2, and Mcl-1) or pro-apoptotic multidomain
members (Bax and Bak) at the mitochondria level to exert their pro-apoptotic
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effects. Recent studies suggest that the interaction between BH3-only Bcl-2
proteins with anti-apoptotic or pro-apoptotic multidomain BcI-2 proteins also take
place on the ER membrane thereby making the ER an important organelle for
initiation and activation of apoptosis [73].

1.4.2.2. The anti-apoptotic Bcl-2 proteins
To date, five anti-apoptotic Bcl-2 proteins have been identified in mammals,
including Bcl-XL, Bcl-2, McI-1, Bcl-w, and A 1. The anti-apoptotic BcI-2 proteins
share up to four conserved BH domains (BH 1-BH4) and the membrane-targeting
hydrophobic carboxy terminal regions. The anti-apoptotic BcI-2 proteins delay or
prevent apoptosis [15]. They are mostly localized on membrane surfaces
including the OMM, the nuclear membrane, and the ER membrane [74]. The antiapoptotic Bcl-2 proteins maintain the OMM integrity and protect cells against a
wide range of apoptotic stimuli, therefore they are essential for cell survival [46,
74, 75]. The activities of the anti-apoptotic Bcl-2 proteins have been well
examined both by overexpression and gene targeting knock-out studies.
Overexpression of all anti-apoptotic Bcl-2 proteins has shown protection of cells
from apoptosis initiated by various apoptotic stimuli [3]. A more defined function
of each of the five anti-apoptotic Bcl-2 proteins has been established using the
gene targeting studies in diverse cell types and tissues [3, 76, 77].
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The founding member Bcl-2 is required for the survival of mature lymphocytes,
melanocyte stem cells and cells of developing kidneys [78, 79]. BcI-xL and Mcl-1
are important for embryonic development, and embryos deficient in either BcI-xL
or McI-1 do not survive. Embryos lacking Bcl-XL expression die in utero, with
extensive apoptosis throughout their developing nervous and hematopoietic
systems [80]. In addition, BcI-xL is also required for the survival of mature
erythrocytes [81, 82]. Mcl-1 deficiency caused failed implantation. By studying
conditional knockout mice, McI-1 is shown to be essential for survival of the
hematopoietic progenitors, mature B- and T- lymphocytes [83]. Bcl-w is required
for sertoli cell survival in the testis [84] and A 1 is critical for neutrophil survival
[85]. The exact molecular and biochemical mechanisms by which anti-apoptotic
BcI-2 proteins keep cells alive is controversial and has not yet been universally
accepted. Depending on the nature of stress to the cells, the anti-apoptotic BcI-2
proteins specifically suppress the activities of the pro-apoptotic Bcl-2 proteins to
maintain cell viability.

1.4.2.2.1. The bc/-x gene

One of the mammalian genes identified as a suppressor of apoptosis is the bc/-x
gene [86]. Boise et al (1993) first discovered the bc/-x gene in chicken, and
identified two distinct Bcl-x cDNAs in human: BCl-XL and BCl-xs, generated from
alternative splicing of the Bcl-x [12]. BCl-XL and BCl-xs have similar structure
except that an internal deletion of 63 amino acids of Bcl-XL due to alternative
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splicing generates Bcl-xs. Whereas Bcl-XL contains all the four BH domains
[BH( 1-4)], Bcl-xs has only two of the four BH domains [BH(3-4)]. Bcl-XL has
remarkable amino acid and structural homology to the founding member of the
BeI-2 family proteins, Bcl-2. Bcl-XL was shown to prevent apoptosis in interleukin3 (IL-3)-dependent cells following deprivation of essential growth factor, but this
was not the case with Bcl-xs. Instead, BeI-Xs promoted apoptosis by inhibiting the
death suppressor activities of Bcl-2. Therefore, Bel-XL and Bcl-xs display opposite
activities in apoptotic regulation [12]. Later studies have shown that Bcl-XL inhibits
apoptosis by forming hetero-dimeric complexes with pro-apoptotic BeI-2 proteins
making them inactive [87]. The role of Bcl-xs in apoptosis is poorly understood,
but is mostly considered pro-apoptotic [81]. Some studies suggest that BeI-Xs
antagonizes the anti-apoptotic functions of Bcl-XL [88, 89], but it is unclear
whether BeI-xs functions simply as an inhibitor of anti-apoptotic BeI-2 proteins or
if it can directly induce apoptosis. Bcl-XL and BeI-xs are expressed in variety of
tissues and their expression is differentially regulated [12]. In cells, Bel-XL is
localized on the mitochondria, the ER and the perinuelear envelope. Bel-XL is the
dominant form of the Bcl-x mRNA expressed in murine tissues during
embryogenesis and postnatal development.

Like other anti-apoptotic BeI-2 proteins, Bcl-XL is overexpressed in many cancer
cells including breast cancer cells, neuroblastomas, myelomas, lymphomas and
hepatomas [74, 75]. Extremely high levels of Bel-XL in cancer cells make them
resistant to chemotherapeutic agents leading to limited apoptosis and poor
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clinical outcome [74]. Therefore, new drugs designed to reduce BcI-XL expression
levels in these cancer cells will complement current cancer therapies.

1.4.2.3. Regulation of OMM permeabilization by the Bcl-2 proteins
How the BcI-2 proteins interact at mitochondrial and ER membrane levels to
regulate apoptosis is still controversial and unclear. Genetic and biochemical
studies showed that Bax and Bak are required for apoptosis and outer
mitochondrial membrane permeabilization (OMMP) [90]. The pro-apoptotic BH3only Bcl-2 proteins are categorized into two groups based on their ability to
interact with Bax and Bak, or the anti-apoptotic BcI-2 proteins. Two models for
Bax and Bak activation have been proposed including the direct activation and
the displacement models [74].

In the direct activation model, the BH3-only BcI-2 proteins are again classified
into two groups known as the direct activators, including Bim, tBid, and Puma,
and the sensitizers (de-repressor), including the rest of the BH3-only Bcl-2
proteins [91]. For the direct activator BH3-only Bcl-2 proteins, direct activators
directly interact with Bax and Bak. Here, in healthy cells, the direct activators are
constitutively active and are kept inactive by forming hetero-dimeric complexes
with anti-apoptotic Bcl-2 proteins. But in dying cells, the direct activators are
dissociated from their anti-apoptotic binding partners by various mechanisms,
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and interact directly with Bax and Bak leading to their activation. The interaction
between Bax and Bak and the direct activators BH3-only Bcl-2 proteins is the
main event necessary for engagement of OMMP. In contrast, activation of Bax
and Bak by the sensitizers BH3-only Bcl-2 proteins is much different. Unable to
directly interact with Bak and Bax, the sensitizer BH3-only BcI-2 proteins cannot
induce Bax and Bak activation directly [74]. Instead, the sensitizers bind to the
anti-apoptotic Bcl-2 proteins with high affinity freeing them from their complexes
with the direct activator BH3-only Bcl-2 proteins. The released direct activators in
turn initiate Bax- and Bak-mediated OMM permeabilization and subsequent
apoptosis cascade [92].

Another proposed model for activation of Bax and Bak is the displacement
model. In this model, Bax and Bak with constitutive activity are kept inactive by
forming complexes with the anti-apoptotic BcI-2 proteins. But in cells undergoing
apoptosis, BH3-only BcI-2 proteins bind to these anti-apoptotic BcI-2 proteins
with higher affinity and displace them from their complexes with Bax and Bak.
Freed Bax and Bak are now activated and are able to induce OMM
permeabilization and subsequent apoptosis.
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Figure 1.6. Activation of outer mitochondrial membrane permeabilization by
Bcl-2 protein family. (A) Direct activation model. Here, the BH3-only
BcI-2 proteins are classified into two groups known as the direct
activators, including Bim, and the sensitizers including Noxa. The direct
activator BH3-only BcI-2 proteins Bim, tBid and Puma interact directly with
Bax and Bak leading to their activation and subsequent apoptosis. The
sensitizer BH3-only Bcl-2 proteins Noxa and Bad do not interact with Bax
and Bak directly. Instead, the sensitizers bind to the anti-apoptotic Bcl-2
proteins with high affinity freeing them from their complexes with the direct
activator BH3-only BcI-2 proteins. The released direct activators in turn
initiate Bax- and Bak-mediated OMM permeabilization and subsequent
apoptosis. (B) Displacement model. In this model, Bax and Bak with
constitutive activity are kept inactive by forming complexes with the antiapoptotic Bcl-2 proteins. But in cells undergoing apoptosis, BH3-only Bcl-2
proteins bind to these anti-apoptotic Bcl-2 proteins with higher affinity and
displace them from their complexes with Bax and Bak. Freed Bax and Bak
are now activated and are able to induce OMMP and subsequent
apoptosis.

29

1.5. Hypothesis and significant of the project
1.5.1. Hypothesis and specific aims
In this thesis, we specifically addressed the molecular, and biochemical
mechanisms through which endogenous Bcl-XL regulate apoptotic signaling
pathways. As mentioned earlier, the BcI-XL protein is generated from alternative
splicing of Bcl-x. Previous studies have shown that mouse embryos deficient die
Bcl-x around day 13 of embryogenesis [80]. BcI-x is therefore indispensable for
embryonic development. Regulation of both the expression and splicing of Bcl-x
during development is important in the determination of susceptibility of cells to
apoptosis [80].

In this thesis, we first developed mouse embryonic fibroblasts (MEFs) either
deficient in BcI-x (knock out, BcI-x-KO) or expressing Bcl-x (wild type, BcI-x-WT).
MEFs were then used to study the molecular mechanisms by which endogenous
Bcl-XL regulates apoptotic signaling pathways. Our overall hypothesis is that
intracellular localization of endogenous Bcl-XL is critical for its antiapoptotic activities and that endogenous Bcl-XL coordinates with other
members of the Bcl-2 protein family to regulate apoptosis. Previous studies
have shown that overexpression of BcI-XL in cells renders them resistant to
apoptosis insults. The exact mechanism of how endogenous BcI-XL prevents
apoptosis is still unclear and controversial. One possible explanation is that
previous research focused on cells overexpressing BcI-XL many fold higher than
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its physiological functional level. As Bcl-XL likely functions by modulating OMM
integrity, enforced overexpression of Bcl-XL could relocate Bcl-xL protein to nonphysiological

locations

inside

cells,

leading

to

unexpected

biological

consequences. Therefore, studying the activities of Bcl-xL at the endogenous
levels will fill critical gaps in our understanding of the molecular and biochemical
mechanisms of BcI-xL, and might provide potential targets for cancer therapy. We
proposed the following specific aims to examine this hypothesis:

Specific aim 1: Investigate how mitochondria- and ER-Iocalized Bcl-XL
regulate apoptosis and Ca 2+ homeostasis. Previous studies have shown that
anti-apoptotic

Bcl-2

proteins

regulate

apoptosis

initiated

from

different

intracellular organelles. As endogenous Bcl-xL is localized in the mitochondria,
the ER, and the cytosol, we investigated the effects of Bcl-XL targeted to these
organelles on apoptosis regulation and Ca 2 + homeostasis. The carboxyl-terminal
transmembrane domain of Bcl-xL which specifically targets BcI-xL to the cytosol
was deleted, and replaced with either the mitochondrial targeting sequence of
listerial (ActA) or the ER targeting sequence of cytochrome b5 (Cb5) which
targets BcI-XL to the mitochondria or the ER respectively. These mutant Bcl-XL
proteins were re-expressed in BcI-x-KO MEFs at levels comparable to that of
endogenous Bcl-xL. BcI-x-KO MEFs re-expressing different BcI-xL mutants were
used to investigate the effects of BcI-XL proteins localized on different organelles
in the regulation of apoptotic stimuli and Ca 2+ homeostasis.
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Specific Aim 2: Study how endogenous Bcl-XL regulates oxidative stressinduced apoptosis. Oxidative stress inducers, including hydrogen peroxide

(H202), cause necrosis and apoptosis. Mild to moderate oxidative stress triggers
apoptosis while severe oxidative stress causes necrosis [93]. The exact
mechanism through which oxidative stress inducers promote apoptosis is unclear
but recent evidence suggests the involvement of the Bcl-2 proteins. Here, we
systematically explored the role of BcI-2 proteins, particularly Bcl-xL, in the
regulation of H202-induced apoptosis.
Specific Aim 3: Examine the important role of LMP during oxidative stressinduced apoptosis. Lysosomal membrane permeabilization (LMP) is important

in H202-induced apoptosis. However, the exact role of LMP in H202-induced
apoptosis or how it is regulated by the complex BcI-2 network is unclear. Here,
we investigated the role of LMP in regulating oxidative stress-induced apoptosis
by examining the temporal relation between LMP and OMM permeabilization.

1.5.2. Significance of the Project
Results from this project elucidate the detailed mechanisms through which
endogenous BcI-XL regulates apoptosis. The data provide information for new
chemotherapeutic drug targets. Since BcI-xL is highly expressed in many cancer
cells to enable them evade apoptosis, drugs designed to inhibit BcI-XL activities
can complement already existing drugs thereby reducing or preventing drug
resistance.
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CHAPTER II
DISTINCT ROLES OF MITOCHONDRIAl- AND ER-lOCALIZED BCl-XL
IN APOPTOSIS REGULATION AND Ca 2+ HOMEOSTASIS
2.1. Introduction

The Bcl-2 family of proteins is major regulator of cellular response to apoptotic
signaling [45]. Since the founding family member BcI-2 was shown to protect
cells from apoptotic insults [94], more than 20 BcI-2-related proteins have been
identified possessing either anti- or pro-apoptotic functions [45]. Among antiapoptotic members, BcI-XL retains the prototypical structural organization of four
BH domains [BH( 1-4)] and a membrane-targeting hydrophobic carboxyl terminal
region [12, 95]. One important characteristic of BcI-2 proteins is that they display
differential interactions with each other and with other regulatory proteins in the
apoptotic cascade, thus profoundly influencing apoptosis [75, 96, 97].

Recent genetic and biochemical studies have revealed a conserved cascade that
leads to the disruption of OMM integrity and the release of apoptosis-inducing
factors into the cytosol, subsequently resulting in destruction of cells [12, 98, 99].
While anti-apoptotic BcI-2 proteins are generally believed to promote cell survival
by preventing OMM disintegration, pro-apoptotic Bcl-2 family members facilitate
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OMM permeabilization during apoptosis [74, 100]. Although most studies have
focused on how Bcl-2 proteins modulate OMM integrity during apoptosis, there is
a large body of evidence indicating that BcI-2 proteins are also localized and
function on the ER membrane [101, 102]. It has been proposed that ER-resident
pro-apoptotic BcI-2 proteins sense insults to the ER, resulting in death-signals
being communicated from the ER to the mitochondria, or apoptosis being directly
initiated at the ER level [103-105].

The involvement of ER in anti-apoptotic signaling has been linked to its role as
intracellular Ca 2+ store [104]. Protection of apoptosis induced by overexpression
of anti-apoptotic BcI-2 proteins including BcI-2, BcI-XL or McI-1 can be attributed
partially to their ability to modulate ER Ca 2+ signals through interactions with the
inositol 1,4,5-trisphosphate receptor (InsP3R) Ca 2+ release channel [106-110].
While these studies have been highly informative, they rely largely on
overexpression systems to study anti-apoptotic BcI-2 proteins, which might not
reveal the activities of endogenous proteins. More importantly, there have been
no studies designed to examine the specific functions of BcI-XL at distinct
organelles in non-overexpression systems.

To address this, we generated Bcl-x-deficient (Bcl-x-KO) MEFs to study the
effect of organelle-specific BcI-XL reexpression on apoptosis and ER Ca 2 +
homeostasis. Bcl-x-KO MEFs displayed increased sensitivity to apoptosis and
disrupted ER Ca 2+ homeostasis. Expressing mitochondrially targeted Bcl-XL in
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these MEFs increased apoptotic protection to the levels comparable to wild-type
MEFs In contrast, expression of ER-Iocalized Bcl-xL completely restored ER Ca 2+
homeostasis but had no effect on apoptotic protection. When expressed in the
wild-type Bcl-xL background, however, ER-targeted Bcl-XL did increase apoptotic
protection. These data show that mitochondrial localization alone is sufficient to
provide protection, but also that it is an absolute requirement for ER-Iocalized
Bcl-xL to be anti-apoptotic.
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2.2. Materials and Methods
2.2.1. Reagents

Etoposide, doxorubicin, H202 and actinomycin 0 were all purchased from Sigma
(St. Louis, MO), while staurosporine was purchased from Enzo (Farmingdale,
NY). All reagents were dissolved in dimethyl sulfoxide (OMSO). Lipofectamine
2000 was purchased from Invitrogen (Carlsbad, CA). Unless otherwise stated, all
other reagents were purchased from Sigma. Antibodies used for western blot and
immunofluorescence analyses were anti-BcI-xS/L S-18 pAb (Santa Cruz, CA, Cat.

# sc-634),

anti-~-actin

mAb (Sigma), anti-Bak pAb (Upstate; Lake Placid, NY,

Cat. # 06-536 NT), anti-Bax N20 pAb (Santa Cruz, Cat. # sc-493), anti-McI-1 pAb
(Epitomics; Burlingame, CA, Cat. # 1239-1), anti-Bcl-2 mAb (Santa Cruz, sc7382), anti-Bcl-w mAb (Cell Signaling Technology, Cat. # 31H4), anti-calreticulin
pAb (Stressgen, Cat. # SPA-600), anti-Tom20 pAb (a gift from Dr. Brian
Wattenberg), peroxidase-conjugated goat anti-rabbit IgG (Thermo; Waltham, MA,
Cat. # 31460), peroxidase-conjugated goat anti-mouse IgG (Thermo, Waltham,
MA, Cat. # 31430), and Alexafluor 594 goat anti-rabbit IgG (Molecular Probes;
Eugene, OR).

2.2.2. Bel-XL expression vector construction

The human BcI-XL cONA was cloned into the mammalian expression vector
pEF6/myc-His A (Invitrogen) to generate the plasmid pEF6-BcI-xL. A stop codon
was introduced after amino acid 210 by polymerase chain reaction (PCR) to
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generate pEF6-BcI-xL -~C. The carboxyl-terminal transmembrane region of Bcl-XL
was replaced by the cytochrome b5 (cb5) membrane targeting sequence which
directs Bcl-XL specifically to the ER membrane, or the membrane targeting
sequence of the listeria protein ActA, which specifically targets BcI-XL to the
mitochondria generating pEF6-BcI-xL-cb5 and pEF6-Bcl-xL-ActA respectively.
The constructs used for intracellular localization experiments were generated by
subcloning appropriate cDNA fragments from pEF6 into pEGFP-C1 (Clontech;
Madison, WI). The respective Bcl-XL mutant plasm ids were expressed into the
Bcl-x-KO MEFs and single clones selected using the limited dilution method.
Clones whose BcI-XL expression levels were comparable to wild type levels
determined by western blot analysis were selected for further studies.

2.2.3. Generation of cell lines

Embryos from an eleven day pregnant Bc/-x heterozygous mouse were isolated.
Primary embryonic cells were dissociated and plated on gelatin-coated dishes.
Seven days later, adherent embryonic cells were immortalized by transfecting
with the pCDNA3 plasmid expressing SV40 large T antigen. The limiting dilution
method was used to isolate single clones from each of the 10 original embryos.
After stable cell lines were established, the expression of Bcl-XL was examined by
western blot (Figure 2.1A). While expression of BcI-xL in the established MEFs
was readily detected by western blot analysis, expression of BcI-xs was
undetectable, indicating that BcI-xL is the predominant splicing product in MEFs
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(Figure 2.1 B). Among ten MEFs developed (from ten different embryos), cell
lines 1, 3, 5 and 6 had higher Bcl-XL expression and were considered to express
Bcl-XL from both alleles (bcl-x+I +, designated wild-type, BcI-x-WT). In contrast,
BcI-XL was not detected in cell lines 2, 4 and 9, designated as Bcl-x-KO MEFs
(bcl-x- I -, knock-out, BcI-x-KO). In cell lines 7, 8, and 10, lower BcI-xL expression

were detected, which could be attributed to heterozygous deletion of the bcl-x
gene (bcl-x+ I-).

To re-express Bcl-xL in BcI-x-KO MEFs, pEF6 plasmids encoding wild-type or
mutant Bcl-xL cDNAs were transfected into wild-type or BcI-x-KO MEFs using
lipofectamine 2000 reagent (Invitrogen). MEFs stably expressing BcI-XL proteins
were obtained by growing transfected cells in the medium containing 1.5 Ilg/ml
blasticidin antibiotics (Invitrogen) and subcloned by a limited dilution approach.
Western blot analysis then was used to determine the expression level of
different Bcl-XL proteins in Bcl-x-KO MEFs. All MEFs were cultured in DMEM
(Mediatech; Manassas, VA) supplemented with 10% FBS (Gemini; West
Sacramento, CA), 100 U/ml penicillin (Mediatech), and 100 IJg/ml streptomycin
(Mediatech) in an incubator with 95% humidity and 5% CO 2 at 37 DC.
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Figure 2.1. Generation of wild-type and 8cl-x-KO MEFs. (A) Embryos were
isolated from an 11-day pregnant mouse heterozygous for the bc/-x gene.
Embryonic cells were dissociated and plated in gelatin-coated 12-well
plates. MEFs were transfected with a plasmid encoding SV40 large T
antigen to be immortalized. The limiting dilution method was used to
isolate single clones from each of 10 original embryos. (8) Bcl-XL
expression in established MEFs was detected by western blot. MEFs from
embryos 2, 4 and 9 were used as BcI-x knockout, while MEFs from
embryos 1, 3, 5 and 6 appear to be wild-type and used as controls. The
expression levels of the other splice variant Bcl-xs was undetected.
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2.2.4. Gene expression analysis
Total RNA from two wild-type and two BcI-x-KO MEF cell lines was isolated using
a RNeasy kit (Qiagen, Germantown, MD).

The quality of total RNA was

confirmed using a 2100 Bioanalyzer (Agilent; Santa Clara, CA). The cRNA was
generated using a WT Expression Kit (Ambion; Austin, TX) and labeled using a
GeneChip WT Terminal Labeling Kit (Affymetrix; Santa Clara, CA). Hybridization
to GeneChip Mouse Gene 1.0 ST Array (Affymetrix) was carried out according to
the manufacturer's protocol. After array processing and scanning, the resulting
raw data were summarized and normalized using RMA in Partek Genomics Suite
6.5 (Partek Inc., S1. Louis, MO) by the University of Louisville Microarray Facility.
Exon level signals were summarized to gene expression levels using mean
values.

The significance of the changes was determined using ANOVA and

applying FOR as multiple test correction.

2.2.5. Cell viability assay
The propidium iodide (PI) exclusion method was used to determine cell viability.
MEFs were plated in 48 well tissue culture plates with a cell density of
approximately 1x1 04 cells per well 24 hours before treatment with the respective
apoptotic stimuli. At the indicated time, MEFs were trypsinized and resuspended
in growth medium containing 1.0 !-Ig/ml PI (Invitrogen).

Cell viability was

measured by PI exclusion method using flow cytometry (FACScalibur, Beckon
Dickinson; San Jose, CA). The experiments were performed in triplicates. Cell
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viability of treated cells was presented as percentage of those of untreated
control cells.

2.2.6. Caspase 3n assay
The Sensolyte

®

Homogeneous R 110 Caspase 3/7 Assay Kit (AnaSpec; San

Jose, CA) was used to directly measure caspase 3/7 activity in MEFs. Twentyfour hours before the treatment, cells were plated in white-walled 96-well plates.
At the indicated time points, measurement was performed according to the
manufacturer's protocols. The fluorescence signal (Ex/Em: 496nm/520mn) was
measured kinetically over 2 hours at an interval of 1 minute by a Gemini EM
microplate spectrofluorometer (Molecular Devices; Sunnyvale, CA). Data were
presented as relative fluorescent units versus time (RFU/min). The slope was
calculated and normalized to those of untreated cells.

2.2.7. Western blot analyses
Cell pellets of MEFs were collected and resuspended in RIPA lysis buffer (150
mM sodium chloride, 1.0% (v/v) Triton X-100, 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulphate, and 50 mM Tris, pH 8.0) containing protease inhibitors
(Complete, Roche; Indianapolis, IN). To remove debris and nuclear materials,
cells were first sonicated for 30 seconds at 10% amplitude (Sonic Dismembrator,
Model 500, Fischer Scientific; Hampton, NH) before centrifugation at 13,200 x
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rpm at 4°C for 10 minutes, and supernatant collected. The protein concentration
was determined using bicinchoninic acid (BCA) assay (Pierce; Rockford, Il).
Twenty micrograms of protein sample were loaded on a 4-12% Bis-Tris gel (BioRad; Hercules, CA) and transferred to PVDF (Millipore; Billerica, MA).

The

membrane filters were incubated in buffer containing 1X PBS, 0.2% (v/v) Tween
20, and 10% (w/v) nonfat dry milk (BioRad) with appropriate primary antibodies
at 4°C overnight or at 25°C for about three hours. After three 10 minute washes
with 1x PBS/O.2% Tween solution, the membrane filters were then incubated with
the appropriate peroxidase-coupled secondary antibodies at 4°C overnight or at
25°C for about three hours. Proteins were detected using the enhanced
chemiluminescent (ECl) detection system (Pierce, Rockford, Il).

2.2.8. Immunofluorescence
Bcl-x-KO MEFs were plated on 18 mm coverslips in a 6-well tissue culture plate
and allowed to grow overnight. Cells were then transiently transfected with the
pEGFP-C1 plasm ids expressing the cDNAs of various Bcl-XL mutants using the
jetPRIME® transfection reagent (Polyplus-transfection SA; Ilikirch, France)
following the manufacturer's instructions. Forty eight hours post transfection;
coverslips were transferred into a 12-well cell culture plate and washed twice with
1.0 ml 1X HBSS (Hanks balanced salt solution).

Following 15 minute fixation

with 0.4 ml 0.4 % paraformaldehyde, cells were washed three times with 1.0 ml
1X HBSS, and then permeabilized with 0.4 ml 0.2 % TritonX-100 for 15 minutes.
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After three washes with 1.0 ml incubation solution (0.02 % TritonX-1 00 and 1.5 %
FBS in 1X HSSB), cells were incubated with primary antibodies in incubation
solution for 1 hour at room temperature. Following three 10 minute washes with
incubation solution, cells were incubated with secondary antibodies for 1 hour at
room temperature, and again washed three times with incubation solution. The
coverslips were then immersed in mounting medium (Oako, Carpinteria, CA), put
on slides, and sealed with nail polish. The fluorescence images were visualized
and acquired using a PlanApo 60x, 1.40 NA oil immersion objectives on a Nikon
Eclipse Ti (Melville, NY) confocal microscope according to the manufacturer's
protocol.

2.2.9. Measurement of cytoplasmic and ER Ca 2+ concentrations
Cytoplasmic and ER Ca 2+ concentrations measurement data were collected by
the Carl White laboratory from the Rosalind Franklin University of Medicine and
Science, North Chicago. For cytoplasmic [Ca 2+], MEFs cultured on glass
coverslips were loaded with 2 IJM fura-2AM (Invitrogen) and incubation at room
temperature for 45 minutes and mounted in a recording chamber positioned on
the stage of an inverted microscope (IX71; Olympus). Fura-2 was alternately
excited at 340 nm and 380 nm and the emitted fluorescence filtered at 510 nm
collected and recorded using a CCO-based imaging system running SimplePCI
software (Hamamatsu; Sewickley, PA). The chamber was continuously perfused
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with HBSS (pH 7.4) at room temperature. A rapid solution changer was used to
switch the composition of the solution bathing the cells under study.

To measure ER [Ca 2+], MEFs were loaded with mag-fura-2AM (5IJM) for 60
minutes at room temperature and perfused with intracellular-like medium (ICM)
containing: 125 mM KCI, 19 mM NaCI, 10 mM Hepes, 1 mM EGTA (pH 7.3 with
KOH) and permeabilized by a 20-30 minute exposure to ICM containing 20 IJM
digitonin.

After 20-30 minute incubation in ICM, stores were Ca 2 +-loaded by

switching to ICM solution with free [Ca 2+] adjusted to 200 nM and 1.5 mM
MgATP. To induce Ca 2+ release, InsP3 was applied in the same Ca 2 +-containing
ICM solution but without MgATP to prevent reuptake. Data were acquired as
described for fura-2 and ratiometric data (R) and were normalized to basal storedepleted levels (Ro). For experiments using flash photolysis of caged-lnsP3, cells
were loaded with the membrane-permeable caged InsP 3 compound ci-lnsPyPM
(0-2, 3-0-isopropyl idene-6-0-(2 -n itro-4, 5-dimethoxy )benzyl-myo-i nositol

1,4,5-

trisphosphate-hexakis(propionoxymethyl) ester; SiChem, Bremen, Germany) by
incubation with 1 IJM for 60 minutes at room temperature.

InsP3 was photo-

released by brief pulses (250 ms) of UV light (350-400 nm) delivered uniformly
throughout the image field. The application of UV pulses precluded the use of
fura-2 as a [Ca 2 +] indicator, therefore, cells were co-loaded with the longer
wavelength dye fluo-2AM (5 IJM; TEFLabs, Inc., Austin, TX) and fluorescence
data (F) normalized to basal levels (Fo).
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2.2.10. Statistical analysis
All experiments were performed in triplicates and each experiment was carried
out at least three times. Statistical analysis was performed using the student ttest and the two way analysis of variance (ANOVA). A P value < 0.05 was
considered significant.
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2.3. Results
2.3.1.

Bcl-x

knock-out does

not cause

compensatory changes

in

expression levels of other Bcl-2 proteins.
As mentioned earlier, BcI-xL is generated from alternative splicing of the Bcl-x
[12]. Massive cell death has been found in a variety of tissues in the Bcl-xdeficient mouse, which dies at embryonic day 13, therefore reflecting its
important role in development [80]. To investigate the function of endogenous
BcI-xL protein in apoptosis regulation, we established MEFs deficient in Bcl-XL
expression (Bcl-x-KO) as described earlier (Figure 2.1). As reduced expression
of the anti-apoptotic Bcl-2 has been shown to affect the expression of other
apoptotic regulators [111], we determined whether bcl-x gene knock out will
cause changes in expression levels of other genes, particularly those of the Bcl-2
protein family. To this purpose, microarray analysis was carried out in two BcI-xKO (lines 4 and 9) and two wild-type (lines 3 and 6) MEFs. Gene expression
levels were determined and the fold change between Bcl-x-KO and wild type
MEFs were determined (Table 2.1). In this assay (GeneChip® Mouse Gene 1.0
ST Array), analysis of multiple probes on different exons was summarized into an
expression value representing all transcripts from the same gene.
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Table 2.1. Changes in mRNA expression of Bcl-2 genes induced by Bcl-x
deficiency were determined by microarray analysis. (A) Data are
represented as fold-changes in mean value of mRNA levels of the antiapoptotic Bcl-2 proteins and the multidomain pro-apoptotic Bcl-2 proteins
in two wild-type and two Bcl-x-KO MEFs. (B) BH3-ony Bcl-2 proteins did
not show changes in mRNA expression levels between wild-type and BcIx-K~

MEFs. Negative values indicate down-regulation.
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As the Bcl-x-deficient mouse was generated by homologous recombination,
some exons in the targeted bcl-x gene were still intact. By this approach, Bcl-x
mRNA was still detectable in BcI-x-deficient cells, and bc/-x mRNA level in Bcl-xKO MEFs was significantly reduced compared with that in wild-type MEFs,
validating the disruption of intact BcI-x mRNA in Bcl-x-KO MEFs. Knocking out of
the BcI-x gene does not cause significant changes in mRNA expression of other
Bcl-2 proteins, including anti-apoptotic BcI-2 proteins (Table 2.1A), pro-apoptotic
multi domain Bcl-2 proteins (Table 2.1A) and pro-apoptotic BH3-only Bcl-2
proteins (Table 2.1 B). Western blot analysis was performed to further validate
that Bcl-x-deficiency does not cause significant changes in BcI-2 protein
expression (Figure 2.2). These results indicate that alterations in cellular
apoptotic signaling in response to apoptotic stimuli in Bcl-x-KO MEFs is attributed
to BcI-Xl deficiency, therefore providing an excellent cell system to study the
molecular and biochemical mechanism of apoptosis regulation by endogenous
BcI-Xl.
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Wild-type
#1
#2
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Bcl-x-KO
#1
#2

,

~.--.

Bcl-2
Mcl-1
Bak
Bax
Actin

Figure 2.2. Bcl-x deficiency does not cause compensatory changes in
expression of other Bcl-2 proteins . Expression of Bcl-2 proteins in the
indicated MEFs was determined by western blot analysis . WT #1 , cell line
3; WT #2 , cell line 6; KO #1 , cell line 9; KO #2 , cell line
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2.3.2. Endogenous Bcl-xL modulates cellular responses to apoptosis
To investigate the functional activity of endogenous Bcl-XL in apoptotic signaling,
two wild-type (cell lines 3 and 6) and two Bcl-x-KO (cell lines 4 and 9) MEFs were
exposed to death causing agents with diverse mechanisms to induce apoptosis
including the topoisomerase inhibitor etoposide (5.0 IJM), the transcriptional
inhibitor actinomycin D (0.2 IJg/ml), the DNA intercalating agent doxorubicin (1.0
IJM), the protein kinase inhibitor staurosporine (5.0 nM), and the oxidative stress
inducer H202 (0.4 mM). When wild-type and BcI-x-KO MEFs were treated with all
of these agents, there was significantly more cell death in Bcl-x-KO compared to
wild type MEFs, except that the protection against actinomycin D in wild type
cells seems to be transient (Figure 2.3A). As BcI-XL is the major splicing product
of the BcI-x gene in MEFs, higher sensitivity of Bcl-x-KO MEFs to apoptotic
insults suggests that endogenous Bcl-XL is able to protect cells against these
apoptotic insults. To confirm further that endogenous Bcl-XL is able to inhibit
apoptosis, caspase 3/7 activity was measured in all the wild-type and Bcl-x-KO
MEFs treated with apoptotic agents.

As shown in Figure 2.3B, caspase 3/7

activity was enhanced in BcI-x-KO MEFs to higher levels than that in wild-type
MEFs upon treatment with all apoptotic insults. The increase in caspase 317
activity correlated with the increase in cell death, suggesting that endogenous
Bcl-XL protects cells against those apoptotic stimuli (Figure 2.3B).
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Figure 2.3. Endogenous Bel-XL modulates cellular response to different
apoptotic stimuli. (A) Apoptosis was induced by the indicated apoptosis
agents: etoposide (5.0 jJM); doxorubicin (1.0 jJM); actinomycin D (0.2
jJg/ml); staurosporine (5.0 nM); or hydrogen peroxide (0.4 mM). 8c1-x-KO
MEFs were more sensitive to these reagents. Data represent mean ±
standard deviation of three independent experiments performed in
triplicate. (B) Caspase 3/7 activity was measured 12 hours following
treatment with etoposide, doxorubicin, or staurosporine or 9 hours after
actinomycin D and H202 treatment using fluorometric assay. Values are
normalized to the values obtained in the untreated control cells. Data are
shown as mean ± S.D. of three independent triplicate experiments.
**P<0.01; ***P<0.001.
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To ensure that enhanced apoptosis observed in Bcl-x-KO MEFs was due to
deficiency in BcI-XL protein expression only, BcI-XL cDNA was re-expressed in
Bcl-x-KO MEFs (cell line 9) to obtain cells with different BcI-XL levels. Three cell
lines were selected; cell line H (high) with Bcl-XL expression level higher than the
endogenous BcI-XL level, cell line M (medium) with BcI-XL expression level
comparable to the endogenous level, and cell line L (low) with expression level
lower than the endogenous BcI-XL level (Figure 2.4A). When cells were treated
with different death stimuli described previously in Figure 2.3A, expression of BclXL in BcI-x-KO MEFs was able to restore the BcI-x-KO MEFs' resistance to
apoptosis (Figure 2.4B). Importantly, BcI-XL protected cells against apoptotic
stimuli in a BcI-XL dose-dependent manner, further substantiating that increased
sensitivity of BcI-x-KO MEFs to death stimuli is caused by the lack of
endogenous Bcl-xL expression (Figure 2.4B). The caspase 3/7 activity of different
cell lines following treatment with the apoptotic agents was measured, and the
correlation between caspase 3/7 activities with levels of cell death was observed,
providing more evidence of the involvement of endogenous BcI-XL in apoptotic
signaling (Figure 2.4C).
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Figure 2.4. Reexpression of Bcl-xL in Bcl-x-KO MEFs restores resistance to
apoptotic stimuli in a Bcl-xL dose-dependent manner. (A) Bcl-XL was
reexpressed in BcI-x-KO MEFs.
determine Bcl-XL expression levels.

Western blot analysis was used to
(B) Viability of the indicated MEFs

was measured in the presence of the indicated apoptotic stimuli. Data
represent mean ± standard deviation of three triplicate independent
experiments. (C) Caspase 3/7 activity was measured under the conditions
described in Figure 2.3B.
untreated control cells.

Values are normalized to the values of

Data show mean ± standard deviation of three

independent experiments performed in triplicate.
***P<O.001.
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*P<O.05; **P<O.01;

2.3.3. Targeting Bcl-xL mutants specifically to the cytosol, the ER, or the
mitochondria
To investigate the anti-apoptotic functions of Bcl-XL localized on different
intracellular organelles, we constructed Bcl-xL mutants that either lacked the
membrane targeting sequence, or contained an ER-specific or a mitochondrialspecific membrane targeting sequences. The carboxyl-terminal transmembrane
sequence of BcI-XL was deleted, and deleting this sequence specifically confines
BcI-XL to the cytosol

(Bcl-xL-~C).

The carboxyl-terminal transmembrane region of

BcI-xL was replaced by the cytochrome b5 (cb5) membrane targeting sequence
which directs BcI-xL specifically to the ER membrane, or the membrane targeting
sequence of the Listeria protein ActA, which specifically targets BcI-XL to
mitochondria (Figure 2.5A). The same targeting sequences have been used
previously to target both anti- and pro-apoptotic BcI-2 proteins to a specific
organelle [105, 112, 113].

To confirm subcellular localization of BcI-XL mutant proteins, cDNAs of the
respective Bcl-xL mutants were subcloned into the plasmid containing the green
fluorescent protein (EGFP-C1), and confocal microscopy was used to examine
their subcellular localization.

GFP-tagged Bcl-xL mutants were transiently

expressed in BcI-x-KO MEFs. The mitochondrial protein Tom20 served as a
mitochondrial maker and the ER protein cal reticulin was selected as an ER
marker.

While

the

intracellular

localization

58

of

GFP-tagged

BcI-xL -ActA

superimposed with that of Tom20, the staining patterns for GFP-8cl-xL-ActA and
calreticulin were clearly distinct (Figures 2.58).

In contrast, GFP-tagged 8cl-xL-cb5 was completely targeted at the ER with its
fluorescence superimposed with that of calreticulin but not Tom20 fluorescence,
indicating that 8c1-xL-cb5 is completely localized at the ER (Figure 2.58).
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Figure 2.5. Generation of mitochondrially targeted and ER-targeted Bcl-xL
mutants. (A) Scheme of the Bcl-XL mutants. The carboxyl-terminal

transmembrane domain of Bcl-XL was deleted

(~C)

and replaced with the

mitochondria-targeting sequence of ActA or the ER-targeting sequence of
cb5. (B) The indicated GFP and BcI-xL fusion proteins were transiently
expressed in BcI-x-KO MEFs. The mitochondrial protein Tom20 was
detected as organelle marker, while the ER protein calreticulin was used
as ER marker. The fluorescence was visualized by confocal microscopy.
Scale bar, 10 j..Im
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2.3.4. Mitochondrially targeted Bcl-XL prevents apoptosis more effectively
than ER-targeted Bcl-xL

To investigate whether BcI-xL proteins targeted at specific organelles mediate
different apoptotic signaling pathways, the mutant BcI-xL proteins were
expressed in BcI-x-KO MEFs (cell line 9) at levels comparable to that of
endogenous Bcl-xL (Figure 2.6A). BcI-x-KO MEFs expressing different BcI-xL
mutants were treated with various death reagents (etoposide, doxorubicin,
actinomycin

0,

staurosporine,

and H202), and cell viability determined.

Expression of BcI-xL-ActA in BcI-x-KO MEFs provided protection against all
apoptotic reagents at the level comparable with that of wild-type BcI-xL (Figure
2.6B). In contrast, both Bcl-xL lacking membrane-anchoring region (Bcl-xL -dC)
and ER-Iocalized BcI-xL (Bcl-xL -cb5) failed to protect cells against any of the
death stimuli examined (Figure 2.6B). These data suggest that mitochondrial
localization is an absolute requirement for Bcl-xL to be protective in various
apoptotic paradigms.

This was further confirmed by the experiments in which caspase 3/7 activity was
measured in response to cell death stimuli. Caspase 3/7 activity of BcI-x-KO
MEFs expressing Bcl-xL -cb5 or Bcl-xL -dC was higher than that of cells
expressing BcI-xL-ActA or wild-type Bcl-xL (Figure 2.6C).
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Figure 2.6. Mitochondrially targeted Bcl-XL inhibits apoptosis

more

efficiently than Bcl-XL targeted at the ER. (A) The indicated BcI-xL
mutants were expressed in BcI-x-KO MEFs at the levels similar to the
endogenous Bcl-XL level. Bcl-xL expression was determined by Western
blot analysis. (B) MEFs expressing different BcI-xL mutants were treated
with either 5.0 j..IM etoposide, 1.0 j..IM doxorubicin, 0.2 j..Ig/ml actinomycin
D, 5.0 nM staurosporine or 0.4 mM H2 0 2 , and cell viability was measured.
The data depict mean ± standard deviation of three independent
experiments. (C) Caspase 3/7 activity was measured as described in
Figure 2.3B. Values are normalized to those of untreated cells. All data
shown are the means ± standard deviation of experiments independently
performed three times. *P<0.05; **P<0.01; ***P<0.001.
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2.3.5. ER-targeted Bcl-xL modulates ER Ca2+ homeostasis
Previously, Li et al. [107] demonstrated that overexpression of Bcl-XL lowers the
steady-state [Ca 2+] within ER stores ([Ca 2+]ER) and affects intracellular Ca 2+
([Ca 2+]j) signaling by modulating channel activities of the ER Ca 2+ release
channel inositol trisphosphate (InsP3) receptor [107, 114]. Here we investigated
whether organelle-targeted BcI-XL proteins influenced InsP3-dependent [Ca 2+]j
signaling. To investigate whether organelle-targeted Bcl-xL proteins influenced
InsP3-dependent [Ca 2+]j signaling, [Ca 2+]j was monitored in response to an
increase in intracellular [lnsP3] evoked by flash photolysis of caged InsP3 (Figure
2.7 A). Maximal InsP3 uncaging and/or receptor activation in these cells was
produced by UV pulses of 250 ms duration. This level of InsP3 evoked larger
[Ca 2+] transients in Bcl-x-KO MEFs compared with wild-type MEFs (Figures 2.7 A
and 2. 7B). Reexpression of Bcl-xL in BcI-x-KO MEFs localized at the ER but not
at mitochondria restored InsP3-evoked Ca 2+ signal to the level observed in wildtype MEFs (Figures 2.7A and Figure 2.7B). These data are consistent with
previous studies showing that BcI-XL overexpression reduces ER Ca 2+ store
content and thus the magnitude of ER Ca 2 + release in response to maximailnsP3
stimulation [107].

As steady-state [Ca 2+]ER is determined by the balance between ER Ca 2+ leakage
and Ca 2+ uptake by sarco/endoplasmic reticulum Ca 2 +-ATPase (SERCA),
[Ca 2+]ER was further evaluated by monitoring [Ca 2+]j in response to inhibition of
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ER Ca 2+ uptake by the SERCA inhibitor cyclopiazonic acid (CPA) in the absence
of external Ca 2+. A smaller Ca 2 + response was evoked by cyclopiazonic acid in
wild-type MEFs compared with BcI-x-KO MEFs (Figure 2.7C). The ER Ca2 +
release was quantified by calculating the integral of the [Ca 2 +]j transient since the
total released [Ca 2 +] more closely reflects the steady-state store content (Figure
2.70). Again, the phenotype of wild-type MEFs was observed only in Bcl-x-KO
MEFs expressing Bcl-XL localized at the ER but not Bcl-XL localized at the
mitochondria. To confirm further the effects of organelle-targeted BcI-XL on ER
. Ca 2 + store, direct measurements of [Ca 2+]ER were also carried out using the low
affinity Ca 2+ indicator Mag-fura-2. Since Mag-fura-2 compartmentalizes in the ER
as well as in the cytoplasm, the plasma membrane was permeabilized to remove
cytoplasmic indicator, and the cells were perfused with a Ca 2 + free solution to
allow passive depletion of ER Ca 2+ store [115]. After equilibration, Ca 2+ uptake
into the store was induced by switching the perfusate to the solution containing
1.5 mM MgATP and 200 nM free [Ca 2+]. Once a steady-state had been reached,
the solution was switched to one containing saturating [lnsP3] (10 !-1M) without
MgATP [116].

As depicted in Figure 2.7E, application of InsP3 induced depletion of the ER Ca 2 +
store. This was a unidirectional measure of Ca 2+ flux since the MgATP required
for SERCA pump function was not present during InsP 3 addition. Consistent with
the previous experiments, BcI-XL deficiency elevated steady-state Ca 2+ in the ER
that was rescued by Bcl-XL expression on the ER (Figures 2.7E and 2.7F). In
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addition, the magnitudes of Ca 2 + release evoked by saturating [lnsP3] mirrored
the filling state of the ER [106] (Figure 2.7G), and are in agreement with the data
from intact cells (Figure 2.7A). Taken together, these data show that expression
of ER-targeted BcI-xL produces phenotypes that are entirely consistent with our
current understanding of how this protein functions at the ER to regulated Ca 2 +
signaling.
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Figure 2.7. ER-Iocalized Bel-XL but not mitochondrially targeted Bcl-XL
modulates ER Ca 2 + homeostasis. (A) Representative [Ca 2+]j responses
in fluo-2AM-loaded cells in response to flash photolysis of caged- InsP3.
(B) Summary bar graphs demonstrate the amplitude of [Ca 2+]j change
after InsP3 uncaging shown in A.

Data represent the mean ± SEM

amplitude of 31-66 cells pooled from at least three independent coverslip
(*P<0.05; ANOVA).

(C) The Ca 2+ content of the ER was indirectly

assessed by monitoring [Ca 2+]j measured by fura-2 in response to acute
inhibition of ER Ca 2+ uptake by cyclopiazonic acid (CPA; 10 jJM).
Representative traces of the indicated cell lines are shown.

(0) Bar

graphs summarizing the total released [Ca 2+] assessed by measuring the
area under the Ca 2+ transient evoked by CPA, (Area Under Curve; AUC).
Data represent the mean ± SEM of at least 50 cells pooled from at least
three separate trials (*P<0.05; ANOVA). (E) Representative recordings of
[Ca 2+]ER in permeabilized cells during store filling initiated by addition of
200 nM Ca 2+ and 1.5 mM MgATP and store depletion by the application of
10 jJM InsP3. Each trace represents mean of 15-20 cells in a single image
field. (F-G) Summary data (mean ± SEM) for 116-146 cells pooled from at
least 3 independent trials. The steady-state uptake capacity of [Ca 2+]ER
after store filling is shown in F and the amplitude of [Ca 2+]ER release in the
presence of InsP 3 is shown in G; (*P<0.05; ANOVA).
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2.3.6. Endogenous Bcl-Xl is essential for anti-apoptotic activities of ER
localized Bcl-Xl.

Overexpressing ER-Iocalized Bcl-Xl in the breast cancer line MCF-7 and Rat-1
fibroblasts has been shown to exhibit broader anti-apoptotic activities than Bcl-xl
targeted at mitochondria [113]. To explore the discrepancy between this finding
and our observations that ER-Iocalized BcI-xl failed to protect against apoptosis
in BcI-x-KO MEFs (Figure 2.6), Bcl-xl-cbS was stably expressed in wild-type and
BcI-x-KO MEFs at the similar levels, and uncloned populations of cells were
obtained (Figure 2.8A). MEFs were then exposed to various death stimuli and
cell viability was measured. While Bcl-xl-cbS did not possess any anti-apoptotic
activities in BcI-x-KO MEFs, expressing the same protein in wild-type MEFs
markedly protected against cell death in all apoptotic paradigms examined, thus
indicating that anti-apoptotic activities of Bcl-xl targeted at ER depends on
endogenous BcI-xl (Figure 2.8B and 2.8C). Examination of caspase 3/7 activity
further confirmed the indispensible role of endogenous Bcl-Xl in the antiapoptotic function of ER-targeted Bcl-xl (Figure 2.80 and 2.8E).
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Figure 2.8. Anti-apoptotic activities of ER-targeted Bcl-XL depend on
endogenous Bcl-xL. (A) Bcl-XL was stably expressed in wild-type and BcIx-K~

MEFs, and expression of BcI-XL in uncloned cell populations was

determined by western blot analysis. Note that the molecular weights of
BcI-XL-cb5 and endogenous BcI-XL are different. (B) Wild-type MEFs with
or without BcI-xL-cb5 expressions were treated with the indicated death
stimuli and cell viability was determined. The data depict mean ± standard
deviation

of

three

independent

experiments.

*P<O.05;

**P<O.01;

***P<O.001. (C) The indicated BcI-x-KO MEFs were treated with the

apoptotic stimuli as shown in (B) and their effects on cell survival were
examined. Mean ± standard deviation of three independent experiments
are shown.

(0) Upon treatment with etoposide, doxorubicin and

staurosporine for 12 hours, actinomycin D for 7 hours and H202 for 9
hours, caspase 3/7 activity of various wild-type MEFs was determined
using a fluorometric assay. Each experiment was performed in triplicate,
and mean ± standard deviation of three independent experiments are
shown. *P<O.05; **P<O.01. (E) Different Bcl-x-KO MEFs were treated with
the indicated apoptotic stimuli, and caspase 3/7 activity was measured.
Data represent the mean ± standard deviation of three independent
experiments.
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2.4. Discussion
Anti-apoptotic Bcl-xL is localized at both mitochondria and the ER [113]. At the
mitochondria, Bcl-xL functions to prevent OMM permeabilization during apoptotic
stress, and also plays an important role in optimizing mitochondrial bioenergetic
function through interactions with various membrane proteins [117-119]. Previous
work demonstrate that BcI-xL functioned at the ER to modulate basal Ca 2 +
signaling and steady-state ER Ca 2+ store content by interacting with the InsP3
receptor [107, 114]. Collectively, these studies reveal that Bcl-xL has diverse
physiological roles that appear to depend on its intracellular localization. In this
specific aim, we sought to understand better the relationship between
intracellular localization of Bcl-xL and apoptosis protection. Our approach was to
generate a BcI-xL-deficient model in which Bcl-xL targeted at different organelles
was expressed and its effects on apoptotic sensitivity were examined.

MEFs

deficient in Bcl-xL expression were established from bc/-x heterozygous mice.
Although alternative splicing of Bcl-x generates Bcl-xL and BcI-xs, BcI-xL is the
major splicing product in MEFs (Figure 2.1).

Unlike reducing BcI-2 expression in LNCaP cells [111], knocking out BcI-xL
expression in MEFs failed to induce compensatory changes in other Bcl-2 family
members (Figure 2.2 and Table 2.1). As expected, MEFs deficient in BcI-xL
expression were more sensitive to various death stimuli compared with wild-type
MEFs. Furthermore, reexpression of wild-type Bcl-xL in Bcl-x-KO MEFs restored
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cellular protection against apoptotic insults in a Bcl-XL dose-dependent fashion
(Figure 2.3). These data demonstrate the validity of this experimental model. Bcl2 protein are localized at both the mitochondria and the ER [101].

To distinguish between the functions of BcI-XL localized at different organelles,
we targeted BcI-XL to a particular organelle by replacing the carboxyl
transmembrane region of Bcl-xL with known organelle targeting sequences. As
mitochondria and the ER have been proposed to interact dynamically with each
other inside cells [120], it is challenging to exclusively target proteins to a given
organelle. Unlike previous studies in which anti-apoptotic BcI-2 proteins targeted
at a particular organelle were overexpressed [112, 113], stable cell lines in the
current study were carefully selected so that mitochondria- or ER-Iocalized Bcl-xL
was expressed at levels comparable to that observed in wild-type MEFs (Figure
2.6). It was expected that lower expression levels would also help ensure more
exclusive targeting. Thus, the distinct patterns in the intracellular residence of
targeted BcI-xL proteins are sufficient to reveal the distinctive roles of BcI-xL
localized on different organelles.

We observed that in the BcI-x-KO background mitochondrially localized BcI-xL
functioned as effectively as wild-type protein in inhibiting apoptosis. On the other
hand, ER-targeted Bcl-XL failed to exhibit any anti-apoptotic activity in BcI-x-KO
MEFs (Figure 2.6). Intriguingly though, Bcl-XL expression at the ER in BcI-x-KO
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MEFs completely rescued abnormal Ca 2 + signaling phenotypes (Figure 2.7). It is
well documented that steady-state ER Ca 2+ correlates closely with apoptotic
sensitivity increased ER Ca 2 +, increased apoptosis, and vice versa. Here,
increased ER Ca 2+ content sensitizes cells to apoptotic stimuli by providing a
greater pool of releasable Ca 2 + that enhances mitochondrial Ca 2+ uptake and
susceptibility to OMM permeabilization [102, 104]. Both overexpression of BcI-2
and Bcl-XL have been shown to lower ER store Ca 2+ [107,114,121, 122]. We
reasoned that the discrepancy could be accounted for if BcI-XL localized at other
organelles was essential for it to be anti-apoptotic at the ER.

Consistent with this reasoning, expression of ER-targeted Bcl-XL was fully
effective in protecting against apoptosis in wild-type MEFs (Figure 2.8). Thus, our
current study provides molecular evidence that the protective function of Bcl-XL at
the ER requires BcI-XL localization at other cellular compartments. We speculate
that this compartment is mitochondria, but further studies are needed to assess
exactly how mitochondrially targeted Bcl-XL is required to sense physiological
changes conferred by BcI-XL at the ER, and how these signals are translated into
apoptotic protection. It is possible that mitochondrial BcI-XL is required to facilitate
ER-to-mitochondrial Ca 2+ transfer, and enhanced mitochondrial bioenergetics
subsequently renders cells to better withstand apoptotic challenges. In summary,
we have developed BcI-xL-deficient MEFs suitable for the study of Bcl-XLregulated apoptotic pathways. We demonstrate that localization at mitochondria
is necessary for endogenous levels of BcI-XL to provide apoptotic protection.
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Furthermore, we show that localization of Bcl-XL at the ER is required for normal
Ca 2+ homeostasis, but that targeting Bcl-xL at the ER only provides increased
apoptotic protection if BcI-xL is also present at other organelles.
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CHAPTER III
ENDOGENOUS BCl-XL MODULATES CEllULAR RESPONSE TO
OXIDATIVE STRESS-INDUCED APOPTOSIS

3.1. Introduction
Apoptosis is regulated by the Bcl-2 family of proteins which can be either proapoptotic or anti-apoptotic [3, 44, 45]. In healthy cells, BcI-XL binds to BH3-only
BcI-2 proteins and/or multidomain Bax and Bak, inhibiting their pro-apoptotic
activities. In dying cells, BH3-only Bcl-2 proteins are activated. Activated BH3only Bcl-2 proteins then either interact with Bax and Bak or bind to anti-apoptotic
BcI-2 proteins releasing them from their complexes with Bax and Bak, thus
activating Bax and Bak. Activated Bax and Bak assemble permeation channels
on OMM, releasing apoptogenic factors including cytochrome c and Diablo/Smac
from the IMS of the mitochondria into the cytosol where they promotes activation
of caspase cascade and apoptosis [54, 75]. Dysregulation of apoptotic signaling
pathways has been associated with the development of many diseases including
cancer, infections and neurodegeneration [1, 3].

Generation of reactive oxygen species (ROS) has also been implicated in
neurodegenerative diseases such as Alzheimer disease and Parkinson's disease
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[13], and in cancer [14]. The oxidative stress inducer H202 causes both apoptosis
and necrosis. Mild to moderate levels of H20 2cause apoptosis while higher levels
induce necrosis [93]. The mechanisms through which oxidative stress inducers
such as H202 promote apoptosis are not completely understood. However,
recent evidence indicates that BcI-2 proteins are involved in regulating oxidative
stress-induced apoptosis [123]. Overexpressing Bcl-2 has been shown to
suppress oxidant-induced apoptosis probably by inhibiting lysosomal membrane
rupture [124, 125]. Several BH3-only BcI-2 proteins have also been found to be
involved in H20 2-induced apoptosis [126-128]. Nonetheless, how anti-apoptotic
BcI-2 proteins coordinate with pro-apoptotic Bcl-2 proteins to regulate apoptosis
remains unclear.

Here, we systematically explored the role of BcI-2 proteins in the regulation of
H202-induced apoptosis. I show that endogenous BcI-XL inhibits cell death
induced by H20 2. Furthermore, upon H20 2 exposure, Noxa up-regulation and
subsequent Mcl-1 expression decrease are essential for apoptosis. Our findings
provide evidence that both anti- and pro-apoptotic Bcl-2 proteins modulate
apoptotic signaling triggered by oxidative stress.
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3.2. Materials and Methods
3.2.1. Reagent and cell culture
H202 was purchased from Sigma. Propidium iodide (PI) was obtained from
Molecular Probes. The Lipofectamine ™ RNAiMAX and Lipofectamine ™ 2000
reagents were obtained from Invitrogen. Mcl-1 and Bcl-XL small interfering RNAs
(siRNAs) were obtained from Santa Cruz Biotechnology, while caspase 3/7
assay kit was purchased from AnaSpec. Antibodies used for western blot
analysis were anti-BcI-xS/L S-18 pAb (polyclonal antibody) and anti-BcI-2 mAb
(monoclonal antibody) from Santa Cruz Biotechnology, anti-!3-actin mAb from
Sigma, anti-McI-1 pAb from Epitomics, anti-BcI-w pAb from Cell Signaling
Technology, peroxidase-conjugated goat anti-(rabbit IgG) and peroxidaseconjugated goat anti-(mouse IgG) from Thermo Fisher Scientific.

MEFs studied here were deficient in BcI-XL (BcI-x-KO), Mcl-1 (Mcl-1-KO), or Noxa
(Noxa-KO). BcI-x-KO MEFs expressing Bcl-XL [BcI-XL(H), BcI-XL(M) and BcI-XL(L)]
were also used. MEFs were cultured in DMEM (Mediatech; Manassas, VA)
supplemented with 10% FBS (Gemini; West Sacramento, CA), 100 U/ml
penicillin (Mediatech), and 100

~g/ml

streptomycin (Mediatech) in an incubator

with 95% humidity and 5% C02 at 37 DC.
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3.2.2. Plasmid construction
The cDNAs of murine anti-apoptotic BcI-2 protein Mcl-1, and a panel of ten proapoptotic BH3-only BcI-2 proteins, including Bim, tBid, Puma, Bad, Bik, Noxa,
Bnip3, Nix, Hrk, and Bmf were subcloned into the retroviral expression vector
pBABE with the enhanced green fluorescent protein (EGFP) serving as a marker
expressed from an internal ribosomal entry site (IRES) [pBABE-IRES-EGFP].
The pBABE-IRES-EGFP plasmid and plasm ids containing cDNAs for the BH3only BcI-2 protein of interest were first digested with the appropriate restriction
enzymes. DNA fragments of the vector (pBABE-IRES-EGFP) and the respective
cDNAs of interest were purified after resolving by agarose gel electrophoresis
and ligated using the Promega ligation reagent (Promega) at 16°C overnight.
The ligated product was then used for Escherichia coli

(~

colt) transformation

reaction with NEB 5aF'fl competent cells (New England Biolabs).Transformed ~
coli was spread on LB plates containing carbenicillin antibiotics. These plates

were also incubated overnight at 37°C for colonies to grow. Then, single ~ coli
colonies were selected, and inoculated in 2 ml LB medium also supplemented
with carbenicillin. Inoculum was then incubated at 37°C for 6-8 hours.

Plasmid DNA of the inoculum was purified using miniprep kit (GenScript). It was
then digested with EcoRI and BamHI restriction endonucleases (REs), and
digested plasmid DNA was analyzed by agarose gel electrophoresis to examine
the presence of DNA fragments with the size of the respective DNA of interest.
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Sequence analysis was performed to determine the exact DNA composition of
the respective pro-apoptotic BH3-only Bcl-2 proteins. Once the exact DNA
composition was determined, the rest of the inoculum in the 2 ml LB media was
transferred into a flask containing 400 ml LB media also supplemented with
carbenicillin, and further incubated at 37 DC overnight. Plasmid DNA in the
culture was purified using the cesium chloride (CsC/) ultra-centrifugation method.
DNA sequence of the purified plasm ids was again confirmed. The purified
plasm ids were then used for transfection and retroviral infection experiments.

3.2.3. Production of retroviral supernatants
The packaging cell line 293T was transfected with the plasmid carrying the
respective gene of interest and the retroviral helper plasmids pMDG2.0 and
pUVMC using the Lipofectamine 2000 reagent as a lipid transfection milieu.
About 106 cells were plated in 6 cm dish and allowed to grow to confluency. For
cDNAs of each of ten BH3-only Bcl-2 proteins, 5 I-1g of plasm ids DNA and 5 I-1g of
retroviral packaging plasmids [pUVMC (2.5 I-1g) and pMDG2.0 (2.5 I-1g)] were
diluted in 0.5 ml of Opti-MEM medium (Invitrogen). In a separate test tube, 20 1-11
of lipofectamine 2000 reagent was diluted in 0.5 ml of Opti-MEM medium. Both
samples were incubated at room temperature for 5 minutes, mixed together and
incubated for another 20 minutes. After 20 minute incubation, each sample was
added to the T293 cells and incubated at 37 DC in a 5% CO 2 incubator for 4-6
hours. Media were replaced with 3 ml fresh media per dish. Cells were incubated
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at 37 DC in a 5% CO 2 incubator for 48-72 hours prior to testing for transgene
expression. Media containing retroviral supernatant was collected 48-72 hours
post transfection. Ten !-Ig/ml of polybrene (Sigma) was added to the retroviral
supernatants

to

increase

infection

efficiency.

The

respective

retroviral

supernatants were used to infect various MEFs.

3.2.4. Cell viability
Cell viability was determined by PI exclusion method using flow cytometry
analysis (FACScalibur, Beckon Dickinson; San Jose, CA). MEFs were plated in
48 well tissue culture plate at a density of approximately 104 cells per well. MEFs
were treated with different apoptotic stimuli or infected with retroviral supernatant
containing the respective pro-apoptotic BH3-only BcI-2 proteins. After the
indicated time, MEFs were collected, 1.0 !-Ig/ml of PI was added and cell viability
was measured.

3.2.5. Caspase 3/7 activity
We used the Sensolyte® Homogeneous R110 Caspase 3/7 Assay Kit (AnaSpec)
to measure caspase 3/7 activity. MEFs were plated at a density of approximately
2.5 x 10 3 cells per well in a white-walled 96-well tissue culture plates and allowed
to grow overnight. Caspase 3/7 activity was determined 9 hours following
treatment with H20 2 according to the manufacturer's protocols. The slope of
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fluorescence increase was calculated and normalized to that of untreated cells,
and data were presented as the relative fluorescence unit versus time (RFU/min).

3.2.6. Western blot analysis
Cell pellets were collected and whole cell Iysates generated by suspending cells
in RIPA lysis buffer [150 mM sodium chloride, 1.0% (v/v) Triton X-100, 0.5%
sodium deoxycholate, 0.1 % sodium dodecyl sulphate, and 50 mM Tris, pH 8.0]
containing protease inhibitors (Complete, Roche; Indianapolis, IN). Total protein
concentration was determined using the BCA assay (Pierce; Rockford, IL). Equal
amount (20 /-lg) of protein per sample was loaded on a 4-12% Bis-Tris gel (BioRad; Hercules, CA), transferred to PVDF (Millipore; Billerica, MA) and used to
determine the expression of the respective proteins, with their appropriate
primary and secondary antibodies indicated.

3.2.7. siRNA transfection
MEFs (BcI-x-WT, Bcl-x-KO, McI-1-WT, and McI-1-KO) were plated in 6-well
tissue culture plates at a cell density of 2 x10 5 per well or in 48-well tissue culture
plates with 1x104 cells in each well 24 hours before transfection. Mcl-1 siRNA
and BcI-XL siRNA with a final concentration of 10 nM were transfected into MEFs
with lipofectamine RNAiMax reagents (Invitrogen) following the manufacturer's
protocol. Twenty four hours post transfection, MEFs were collected and the gene
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silencing efficiency was examined by western blot analysis. Cell viability was
measured using the PI exclusion method to determine if knock down of the two
anti-apoptotic Bcl-2 proteins will cause spontaneous apoptosis.

3.2.8. Quantitative real-time polymerase chain reaction (qPCR)
Bcl-x wild-type, Noxa wild-type, and Noxa-KO MEFs were incubated with 0.4 mM
H202 for 0,7 and 15 hours in 10 cm tissue culture plates. Total RNA was isolated
using the RNeasy kit (Qiagen) following the manufacturer's instructions. RNA
concentration was determined using a NanoDrop 8000 Spectrophotometer
(Thermo) and the quality of total RNA determined with a 2100 Bioanalyzer
(Agilent). One microgram of total RNA was used for reverse transcription
polymerase chain reaction (rt-PCR) to generate cDNA using a High Capacity
Reverse Transcript Kit (ABI; Forest City, CA) according to the manufacturer's
instructions. The rt-PCR product was used in a TaqMan gene expression assay
(ABI, Forest City, CA).The TaqMan 20x probes for the ten BH3-only Bcl-2
proteins were used to detect expression levels of mRNA of the respective BH3only Bcl-2 proteins with tubulin serving as endogenous control.

3.2.9. Statistical analysis
All experiments were performed in triplicates and results expressed as mean ±
standard deviation of at least three independent triplicate experiments. A two tail
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student's t test was carried out and p:s; 0.05 was considered significant between
samples and their respective controls.
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3.3. Results

3.3.1. Endogenous Bcl-Xl inhibits H202-induced apoptosis

To determine whether endogenous BcI-2 proteins might be involved in the
regulation of oxidative stress-induced apoptosis, we exposed MEFs described
before in Figure 2.1 H202. Both wild-type and BcI-x-KO MEFs were incubated
with 0.1-0.6 mM of H202 and cell viability was measured. Exposure to various
concentrations of H202 resulted in more cell death in BcI-x-KO MEFs compared
with wild-type MEFs, and cytotoxicity of H202 was dose-dependent (Figure 3.1A).
Among all concentrations examined, 0.4 mM H202 exposure generated the
biggest difference in viability between wild-type and Bcl-x-KO MEFs. It has been
reported that moderate H202 concentrations cause apoptotic cell death and
higher levels of H202 induce necrosis [93].

Following 0.1-0.6 mM H 202 exposure, caspase 3/7 activity was measured to
explore the range of H20 2 concentrations that were inducing apoptosis in wildtype and Bcl-x-KO MEFs (Figure 3.1 B). For both cell lines, MEFs treated with
0.4 mM H20 2 exhibited the highest levels of caspase 3/7 activity. Exposure to
H202 concentrations higher than 0.4 mM induced more cell death, but lower

caspase 3/7 activity, suggesting that 0.4 mM H202 provides the optimal level of
apoptosis, and higher doses cause increasing MEF cell necrosis. Importantly,
caspase 3/7 activity in BcI-x-KO MEFs treated with 0.4 mM H 202 was higher than
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that in wild-type MEFs, indicating that endogenous Bcl-xL is crucial for protection
against H202-induced apoptosis.
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Figure 3.1. Endogenous Bcl-XL inhibits H202-induced apoptosis (A) Wildtype and Bcl-x-KO MEFs were treated with 0.1-0 .6 mM

H 20 2

for the

indicated times and cell viability was measured . Results are mean±
standard deviation for three independent experiments performed in
triplicate . **P<0 .01 ; Student's unpaired t test. (B) Fluorimetric assays were
carried out to determine caspase 3/7 activity after 9 hour of treatment with

0.1-0.6 mM H20 2 . Values are normalized to those of the untreated cells,
and results are mean±S.D. for three independent experiments performed
in triplicate. *P<0 .05 ; **P<0 .01 ; Student's unpaired t test.
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3.3.2. Endogenous Bcl-XL differentially antagonizes the activity of different
pro-apoptotic BH3-only Bcl-2 proteins
To determine the effects of pro-apoptotic BH3-only BcI-2 proteins on cell viability
of wild-type and Bcl-x-KO MEFs, the cDNA of a panel of ten pro-apoptotic BH3only BcI-2 proteins including Bad, Bnip3, Nix, Bim, Bik, tBid, Bmf, Hrk, Puma and
Noxa were first subcloned into the retroviral expressing vector pBABE having an
enhanced green fluorescent protein (EGFP) as a marker expressed from an
Internal Ribosomal Entry Site (IRES) [pBABEIIRES/EGFPl Each plasmid
carrying the gene of interest was first transfected into T293 cells and retroviral
supernatant collected. Wild-type and Bcl-x-KO MEFs were infected with retroviral
supernatant expressing the individual BH3-only Bcl-2 proteins. As indicated by
EGFP fluorescence intensity of cells, more than 95% of infected MEFs
expressed the individual BH3-only BcI-2 proteins. Quantitative real time
polymerase chain reaction (qPCR) was performed to ensure that each BH3-only
BcI-2 protein was expressed at similar levels in both wild-type and Bcl-x-KO
MEFs (Figure 3.2).

Cell viability was measured at 0, 24 and 48 hours using the PI exclusion method.
The BH3-only Bcl-2 proteins were categorized into three groups based on their
effects on cell viability of MEFs. The first group includes Bad, Bnip3, Nix, and Bik.
As shown in Figure 3.3, when wild-type and BcI-x-KO MEFs were infected with
retroviral supernatant containing Bad, Bnip3, Nix, or Bik respectively, there was
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no change in cell viability. Neither wild-type nor BcI-x-KO MEFs underwent
apoptosis upon infection, indicating that these proteins do not directly interact
with endogenous BcI-XL. The second group includes tBid, Puma, Bim, Bmf and
Hrk. When tBid, Puma, Bim, Bmf or Hrk were expressed in wild-type and Bcl-xKO MEFs, there was no significant difference in cell viability. Both MEFs died at
the same rate, showing that BcI-XL was not able to prevent cell death initiated by
these BH3-only BcI-2 proteins (Figure 3.3). Finally, Noxa expression induced
significant cell death in Bcl-x-KO MEFs but not in wild-type MEFs, indicating that
the endogenous Bcl-XL is able to completely inhibit pro-apoptotic activities of
Noxa (Figure 3.3).

These data suggest that endogenous levels of Bcl-XL mediate cellular responses
to pro-apoptotic BH3-only BcI-2 protein expression by differentially antagonizing
their activities. When these ten pro-apoptotic BH3-only Bcl-2 proteins were
treated with the Bcl-x-KO MEFs reexpressing different BcI-XL levels described in
Figure 2.4A above, we found out that reexpression of Bcl-XL in the Bcl-x-KO
MEFs also restored their ability to prevent apoptosis in a BcI-XL dose-dependent
manner (Figure 3.4).
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Figure 3.2. Expression levels of pro-apoptotic BH3-only Bcl-2 proteins in
MEFs. Wild-type and BcI-x-KO MEFs were infected with retroviral
supernatants expressing the different pro-apoptotic BH3-only Bcl-2
proteins for 8 hours. Expression of the indicated BH3-only Bcl-2 proteins
was determined by qPCR analysis. Note that the probes for human Bid
were used to detect expression of tBid in MEFs and endogenous Bid
expression levels in MEFs were almost undetectable. Data represents
mean ± standard deviation of three independent experiments performed in
triplicates.
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3.3.3. Endogenous Bcl-XL prevents H20 2- and Noxa-induced apoptosis in a
similar fashion
Next, we looked at the effect of endogenous BcI-XL on apoptosis induced by the
oxidative stress inducers H202, and the pro-apoptotic BH3-only BcI-2 proteins.
Results demonstrate that endogenous Bcl-XL most efficiently inhibits apoptosis
induced by H202 (Figure 2.3A and Figure 3.1A), and the pro-apoptotic BH3-only
BcI-2 protein Noxa (Figure 3.3) in a similar manner. But, how the BcI-2 proteins
are involved in oxidative stress-induced apoptosis is largely unclear. Since
endogenous Bcl-XL was able to prevent Noxa- and H202-induced apoptosis in a
similar fashion, I explored further the mechanism by which H202 induces
apoptosis. Previous studies have shown that Noxa interacts with the antiapoptotic Bcl-2 protein McI-1 and sequesters it for degradation. I therefore
proposed that the oxidative stress inducer H202 activates Noxa expression,
which in turn leads to Mcl-1 degradation and subsequent apoptosis. Therefore, I
investigated the sequence of events involving the BcI-2 proteins BcI-XL, Noxa and
McI-1 during H202-induced apoptosis.

3.3.4. Noxa mediates H202-induced apoptosis
To investigate the role of the pro-apoptotic BH3-only BcI-2 proteins on apoptosis
induced by H202, I carried out microarray analysis to determine the global
changes in mRNA expression levels of the different BcI-2 proteins in wild type
MEFs. Upon H202 exposure, the most notable increase in gene expression within
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the 8H3-only 8cl-2 protein family was Noxa, while the other 8H3-only 8c1-2
proteins showed smaller changes in gene expression (Figure 3.5A). Noxa gene
expression level was dramatically ~ncreased at the 7 hour time point, and the fold
increase was smaller at the 15 hour time point, suggesting that the increase
might be transient. The upregulation of Noxa mRNA was also validated using
qPCR, indicating that Noxa expression is increased during oxidative stress
inducer, H202-induced apoptosis (Figure 3.58).
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Figure 3.5. H20 2 induces Noxa expression. (A) Noxa mRNA displayed the
greatest increase upon H202 treatment among BH3-only Bcl-2 proteins.
Microarray analysis was used to determine changes of mRNA levels in
wild-type MEFs after exposure to 0.4 mM H202 for 7 hours and 15 hours.
The fold change in mRNA levels of different BH3-only Bcl-2 proteins was
calculated using the values at 0 hour time point as a control.
Quantitative

real-time

polymerase

chain

reaction

(qPCR)

(8)

showed

expression levels of Noxa and Puma mRNA after treating wild-type MEFs
with 0.4 mM H20 2. Data represent the mean ± standard deviation of three
independent experiments performed in triplicates. Asterisks indicate P <
0.05 (*), P < 0.01 (**), or P < 0.001 (***), Student's unpaired t test.
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To further explore the importance of Noxa in H 20 2-induced apoptosis, I
investigated the effects of decreased Noxa expression on cell sensitivity to H202.
MEFs deficient in Noxa expression (Noxa-KO) and their wild-type counterparts
were provided by Professor Andreas Strasser (Walter and Eliza Hall Institute of
Medical Research, Parkville, VIC Australia). Due to a lack of effective anti-murine
Noxa antibodies, I failed to detect Noxa protein expression in any MEFs
examined. However, the results from qPCR experiments confirmed that Noxa
mRNA was expressed in wild-type but not in Noxa-KO MEF cells (Figure 3.6A).
When treated with 0.1-0.6 mM H20 2, MEF cell death increased in a H202 dosedependent manner and wild-type MEFs were more sensitive to H20 2 than NoxaKO MEFs, providing evidence that H202-induced apoptosis is primarily mediated
by Noxa in MEFs (Figure 3.68). Furthermore, the biggest difference in cell
viability between wild-type and Noxa-KO MEFs was observed for MEFs treated
with 0.4 mM H202. Importantly, 0.4 mM H202 exposure induced highest caspase
3/7 activity among all concentrations tested (Figure 3.6C).
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0.05 (*), P < 0.01 (**), or P < 0.001 (***), Student's unpaired t test.
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3.3.5. Reduction of Mcl-1 expression in response to H202 treatment is
dependent on Noxa but not on Bcl-xL.
As the pro-apoptotic BH3-only BcI-2 protein Noxa has been shown to interact
with the anti-apoptotic Bcl-2 protein McI-1 and cause Mcl-1 degradation [129], we
explored whether H202-induced Noxa expression

led to reduced Mcl-1

expression levels. Noxa wild-type and Noxa-KO MEFs were treated with H202,
and McI-1 expression levels were determined by western blot analysis (Figure
3.7A and 3.7B). Upon H202 exposure, McI-1 protein was decreased in Noxaexpressing wild-type cells in a time-dependent manner. In contrast, Mcl-1
expression was not affected by H202 in Noxa-KO MEFs (Figure 3.7A and 3.7B).
The lack of Mcl-1 downregulation in Noxa-KO MEFs provides more evidence that
H202-induced Mcl-1 expression reduction is mediated by Noxa. Since proapoptotic activities of Noxa depend on endogenous BcI-XL expression (Figure
3.3), we examined the influence of endogenous BcI-XL in McI-1 expression
decrease caused by H202 exposure. When treated with H202, McI-1 expression
levels decreased to comparable degrees in both wild-type and Bcl-x-KO MEFs,
indicating that Bcl-XL does not influence the McI-1 down-regulation induced by
H202 (Figure 3.7C and 3.70).
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Figure 3.7. Mcl-1 expression reduction in response to H202 depends on
Noxa but not Bcl-XL' (A) Wild-type and Noxa-KO MEFs were exposed to
0.4 mM H20 2 for the indicated time and cell Iysates were collected.
Western blot analysis determined the Mcl-1 expression levels.
represent one of three independent experiments.

Images

(B) Normalized

summary of McI-1 levels in the indicated cell lines shown in (A).

The

values of Mcl-1 levels were normalized to those in the untreated cells.
Data represent the mean ± standard deviation of three independent
experiments. (C) Wild-type and 8c1-x-KO MEFs were treated with 0.4 mM
H20 2 and cell Iysates were obtained at the indicated time points. McI-1
expression levels were assessed by western blot analysis. The results of
one of three independent experiments are shown. (0) The levels of Mcl-1
shown in (C) were normalized as described in (8). Data represent the
mean ± standard deviation of three independent experiments. Asterisks
indicate P < 0.05 (*) or P < 0.01 (**), and (ns) no significance, Student's
unpaired t test.
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3.3.6. Mcl-1 overexpression inhibits H20'2-induced apoptosis
To further explore the importance of Mcl-1 reduction in H202-induced apoptosis,
McI-1 was overexpressed in wild-type and 8cl-x-KO MEFs by retroviral infection
and western blot analysis used to determine McI-1 expression levels in MEFs
(Figure 3.8A). MEFs with different McI-1 expression levels were exposed to 0.4
mM H202 and cell viability was determined. Overexpressed McI-1 prevented
H202-induced apoptosis in both wild-type and 8c1-x-KO MEFs (Figure 3.88). In
addition, caspase 3/7 activity measurement confirmed that McI-1 overexpression
inhibited apoptosis induced by H202 (Figure 3.8C), in support of the notion that
Noxa-mediated decrease in McI-1 might be involved in H202 cytotoxicity.
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blot analysis determined the expression levels of Mcl-1 in the indicated
cell lines.
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H202.

Values were normalized to those of the untreated cells. Data are shown as
the mean ± standard deviation of three independent experiments
performed in triplicate. Asterisks indicate P < 0.05 (*) or P < 0.01 (**),
Student's unpaired t test.
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3.3.7. Reduction of both Bcl-XL and Mcl-1 protein expression in MEFs
induces spontaneous apoptosis (synthetic lethality).
We have shown that lacking endogenous Bcl-XL expression sensitized cells to
both H202 treatment (Figure 2.3A) and Noxa expression (Figure 3.3), and Noxadependent decrease in McI-1 expression is important for cell death induced by
H202 (Figure 3.8B). Therefore, we reasoned that Bcl-XL and Mcl-1 were two antiapoptotic BcI-2 proteins critical to prevent apoptosis in general and H20 2 -induced
apoptosis in particular. Thus, we investigated the influence of reducing BcI-XL and
Mcl-1 expression simultaneously on cell survival. To this purpose, we first
reduced McI-1 expression in Bcl-x-KO MEFs. Upon Mcl-1 siRNA transient
expression, Mcl-1 expression decreased in both wild-type and Bcl-x-KO MEFs,
whereas expression of other anti-apoptotic Bcl-2 proteins, including Bcl-XL, BcI-2
and BcI-w, appeared unchanged (Figure 3.9A). The reduction of Mcl-1
expression in wild-type MEFs was more dramatic than that in Bcl-x-KO MEFs
(Figure

3.9B).

While

knocking

down

Mcl-1

expression failed

to

affect

spontaneous wild-type cell death, reduced McI-1 expression in Bcl-x-KO MEFs
caused significantly more cell death (Figure 3.9C).

To further validate the role of BcI-XL and Mcl-1 in maintaining cell survival, a
reciprocal experiment was performed to knock down Bcl-XL expression in wildtype and McI-1-KO MEFs (Figure 3.90). Twenty four hours following transfection,
Bcl-XL expression was reduced to comparable levels in wild-type and McI-1-KO
MEFs by Bcl-XL siRNA (Figure 3.9E). Much higher levels of spontaneous
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apoptosis were observed in McI-1-KO MEFs with reduced Bcl-xL expression,
whereas decreased Bcl-xL expression did not affect cell survival in wild-type
MEFs (Figure 3.9F). Overall, these results indicate that BcI-xL and McI-1 are
important in maintaining MEF cell survival and suppressing both of them leads to
spontaneous apoptosis.
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Figure 3.9. Reduction in Bcl-xl and Mcl-1 expression simultaneously
induces spontaneous apoptosis. (A) Expression of Mcl-1 and several
anti-apoptotic BcI-2 proteins in the indicated wild-type and Bcl-x-KO MEFs
were determined by western blot 24 hours post siRNA transfection. (B)
The summary of normalized McI-1 levels shown in (A). McI-1 levels were
normalized to those in the untreated cells. Data represent the mean ±
standard deviation of three independent experiments. (C) Reduction of
Mcl-1 expression in Bcl-x-KO MEFs induced spontaneous cell death 24
hours following siRNA transfection. Mean ± standard deviation for three
independent experiments are shown. (0) Bcl-XL expression was reduced
in both wild-type and Mcl-1-KO MEFs by siRNA 24 hours after
transfection. (E) Normalized summary of BcI-XL levels in the indicated cell
lines shown in (D). Data represent the mean ± standard deviation of three
different experiments. (F) Decreasing BcI-XL expression caused cell death
in McI-1-KO MEFs 24 hours following transfection. Mean ± standard
deviation for three independent experiments are shown. Asterisks indicate
P < 0.05 (*) or P < 0.001 (***), Student's unpaired t test.
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3.4. Discussion
Oxidative stress-induced apoptosis is a well-described phenomenon, but the
precise mechanisms through which oxidative stress is coupled with ultimate cell
death are not completely clear. In this specific aim, I investigated the roles of
both anti- apoptotic and pro-apoptotic Bcl-2 proteins in regulating cell death
caused by oxidative stress in the form of H202. Upon H202 exposure,
endogenous anti-apoptotic BcI-XL seemed to be essential for MEF cell survival.
Systematic examination of the involvement of pro-apoptotic BH3-only BcI-2
proteins in H202-induced apoptosis revealed that Noxa was the major mediator of
H202 cytotoxicity in MEFs. Furthermore, H20 2-induced Noxa expression led to
reduction in Mcl-1 expression, which in turn co-operated with decreased BcI-XL
levels to trigger apoptotic signaling. Overall, our studies provide molecular
evidence that Bcl-2 family of proteins function co-operatively to modulate cellular
responses to oxidative stress.

Cellular responses to any apoptotic trigger, including oxidative stress, are
modulated by complex BcI-2 networks [46, 75]. In response to apoptotic stimuli,
activity of BH3-only BcI-2 proteins is up-regulated either by an increase in
transcription or by post-translational modification, such as caspase-8-mediated
proteolysis of Bid [130], phosphorylation of Bim [131], and dephosphorylation of
Bad [132]. This present study focuses on investigating whether transcriptional
induction of a particular BH3-only BcI-2 protein mediates oxidative stress-
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triggered cell death. The possible role of post-translational modification of BH3only Bcl-2 proteins in oxidative stress-induced apoptosis is not addressed here. It
is conceivable that post-translational modification of one or more BH3-only Bcl-2
proteins might also be involved in apoptosis induced by oxidative stress. Modest
caspase 3/7 activity observed in H20 2-treated Noxa-KO MEFs suggests that
BH3-only Bcl-2 proteins other than Noxa are also involved in oxidative stressinduced apoptosis, albeit a minor role in MEFs.

Several BH3-only BcI-2 proteins have been proposed to be involved in cell death
caused by H202. Murine retinal explants deficient in Bim expression are more
resistant to H20 2 treatment compared with retinal explants expressing Bim [133].
In fibroblasts, Bik expression is crucial for H202-triggered cell death [127]. In
agreement with our observations, Noxa is largely responsible for the cytotoxicity
of H202 in T leukemia Jurkat cells [128]. Thus, the involvement of a particular
BH3-only Bcl-2 protein in H202-induced apoptosis appears to depend on cell
type, which could be attributed to cell type-specific transcriptional responses to
cell death stimuli. While the proline- and acid-rich (PAR) subfamily of basic
leucine-zipper (bZIP) transcriptional factor family is responsible for Bik
expression increase in H202-exposed MEFs [127], the activating transcription
factor 4 (ATF4) has been implicated in the induction of Noxa expression in Jurkat
cells upon H20 2 exposure [128]. It is still unclear how oxidative stress-induced
apoptosis signalling is transduced into the nucleus to induce the transcription of
BH3-only Bcl-2 proteins. The cytotoxicity of oxidative stress is believed to be
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mediated by reactive oxygen species (ROS) and reactive iron [134, 135].
Membrane rupture of Iysosomes, the organelle with most abundant labile iron,
results in translocation of redox-active iron to the nucleus, which might be
responsible for generating

oxidative

damage to

DNA and

subsequent

transcriptional responses [136]. In support of this model, the Iysosomotropic iron
chelator deferoxamine (DFO) prevents production of more reactive species of
ROS, lysosomal rupture and subsequent cell death [134, 135, 137].

It has been proposed that BH3-only BcI-2 proteins function to inhibit activities of
anti-apoptotic Bcl-2 proteins and/or activate multidomain effector BcI-2 proteins
Bak and Bax [74]. The differential interactions between BH3-only Bcl-2 proteins
and anti-apoptotic BcI-2 proteins enable the complex BcI-2 network to modulate
apoptotic signalling. Through BH3 peptide and protein binding assays, the
interactions between BH3-only Bcl-2 proteins and anti-apoptotic Bcl-2 proteins
have been quantified [138, 139]. While some BH3-only BcI-2 proteins, such as
Bim and Puma, engage all anti-apoptotic Bcl-2 proteins, Noxa is believed to
interact with McI-1 with highest affinity in vitro. Although Bim, Puma, Bmf, and
Hrk have been shown to bind to Bcl-XL, endogenous BcI-XL failed to provide any
protection against the expression of each of these BH3-only BcI-2 proteins
(Figure 3.3). One possible scenario is that endogenous BcI-XL was overwhelmed
by expression of these BH3-only BcI-2 proteins. However, our current knowledge
of the interactions between BH3-only BcI-2 proteins and Bcl-XL are largely based
on studies of BH3 domain peptides and recombinant proteins. The results
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obtained from these in vitro studies might not truthfully reflect the physiological
interactions between endogenous Bcl-XL and BH3-only Bcl-2 proteins inside
cells. Remarkably, Noxa was the only BH3-only BcI-2 protein whose proapoptotic activities were completely abolished by endogenous Bcl-XL, even
though cytotoxicity of Noxa on Bcl-x-KO MEFs was comparable to those of Bim,
Puma, Bmf, tBid and Hrk (Figure 3.3).

The simple explanation for this observation is that endogenous BcI-XL directly
binds to Noxa and completely sequesters all ectopically expressed Noxa.
Indeed, a recent study indicates that BcI-XL may directly interact with Noxa in
HeLa cells [140]. However, the observed interaction between BcI-XL and Noxa is
weak, as only overexpressed BcI-XL but not endogenous Bcl-XL has been found
to bind Noxa following DNA damage. This seems not to be the case in our
studies. If endogenous BcI-XL directly bound and sequestered Noxa in H202treated MEFs, reduction of McI-1 expression would be more dramatic in BcI-x-KO
MEFs, since more unbound Noxa proteins would be available to engage Mcl-1 in
the absence of BcI-XL. In fact, similar reduction of Mcl-1 expression was observed
in wild-type and BcI-x-KO MEFs (Figure 3.7), suggesting that Noxa does not
directly engage endogenous Bcl-XL in MEFs. Instead, our studies provide
evidence that H20 2-induced Noxa expression causes McI-1 down-regulation,
which is involved in H202 cytotoxicity.
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Our data demonstrate that BcI-XL and Mcl-1 are two major anti-apoptotic Bcl-2
proteins protecting cells against basal pro-apoptotic activities in healthy cells.
Apoptosis was initiated when McI-1 expression was reduced in BcI-x-KO MEFs
or Bcl-XL expression was decreased in the MEFs lacking Mcl-1 expression
(Figure 3.9), which is consistent with the previous studies in HeLa cells [140].
The nature of basal pro-apoptotic activities triggering apoptosis in the absence of
BcI-XL and Mcl-1 is not completely understood. One intriguing possibility is that
multidomain Bak is kept inactive by Bcl-XL and Mcl-1 in healthy cells [129]. But in
the presence of apoptotic stimuli, BH3-only BcI-2 proteins are activated to
displace both BcI-XL and Mcl-1 from Bak, such as Bad for BcI-XL and Noxa for
Mcl-1. Bak is then freed and activated, and activated Bak subsequently forms
permeation channels on mitochondria and promotes OMM permeabilization.
However, other studies indicate that Bak is not kept in check by BcI-XL and or
McI-1 [141]. Instead, the mitochondrial protein voltage-dependent anion channel 2
(VDAC2) is found to sequester Bak and keep it inactive. Whether Bak activation
is responsible for oxidative stress-induced cell death or not warrants further
investigation. In summary, our studies define the important roles of several
members of the Bcl-2 protein family in H202-induced apoptosis (Figure 3.10).
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Mcl-1

Apoptosis

Survival

Figure 3.10. Bcl-2 proteins coordinately regulate H202-induced apoptosis.

Oxidative stress (H202) induces Noxa expression, leading to reduction of
Mcl-1 expression. In the absence of BcI-xL, cells undergo apoptosis.
Endogenous Bcl-xL protects against cell death induced by H202.
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CHAPTER IV
THE IMPORTANT ROLE OF LYSOSOMAL MEMBRANE PERMEABILIZATION
DURING OXIDATIVE STRESS-INDUCED APOPTOSIS
4.1. Introduction

Apoptosis is regulated by the BcI-2 family of proteins, which can either be proapoptotic or anti-apoptotic [3, 44, 45]. Pro-apoptotic Bcl-2 proteins promote or
induce apoptosis by increasing OMMP, whereas anti-apoptotic BcI-2 proteins
inhibit OMMP and prevent or delay apoptosis [46, 74, 75]. Although mitochondria
playa central role in apoptosis regulation, other organelles including the ER, the
golgi aparatus, and the Iysosomes are also involved in apoptosis regulation [53,
142, 143]. Lysosomes are major intracellular organelles responsible for
degrading and recycling of cellular components. Lysosomes contain at least 50
hydrolytic enzymes including nucleases, proteases, phospholipases, lipases,
phosphatases, sulfatases and glycosidases which, upon release, can degrade
macromolecules in the cytosol [144].

The best characterized lysosomal enzymes belong to the cathepsin protease
family. A wide variety of stressors including osmotic stress, growth factor
deprivation, death receptor activation, proteasome inhibitors and oxidative stress
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inducers have been shown to target Iysosomes and cause lysosomal membrane
permeabilization (LMP) through which lysosomal hydrolytic enzymes are
released into the cytosol [145]. The degree of lysosomal damage determines the
cell's fate. Massive lysosomal damage causes an excessive release of lysosomal
contents into the cytosol resulting in indiscriminate degradation of cellular
contents and cytoplasmic acidification, which in turn promotes cell death by
necrosis. On the other hand, selective or partial lysosomal damage induces cell
death by apoptosis [146-148]. For instance, in TNFa-treated cells, cathepsin B, 0
and L released into the cytosol trigger apoptosis by converting the inactive full
length pro-apoptotic BH3-only BcI-2 protein Bid into its truncated (activated) form
(tBid) promoting subsequent OMMP and caspase activation [145, 149].

Oxidative stress inducers, including H202, are capable of inducing cell death by
both necrosis and apoptosis; mild oxidative stress causes apoptosis whereas
severe oxidative stress triggers necrosis [93]. The extent of oxidative stress
determines the degree of lysosomal membrane damage. In Iysosomes, H202
interacts with iron to generate highly reactive hydroxyl radicals that initiate lipid
peroxidation of lysosomal membranes and subsequent LMP. In support of this
model, the iron chelating agent desferrioxamine (DFO) has been shown to
abolish oxidative stress-triggered LMP and apoptosis [150]. However, the
involvement of LMP in oxidative stress-induced apoptosis signaling and how
LMP is modulated by the Bcl-2 protein network are unclear. Here, I investigated
the temporal relation between LMP and OMMP during oxidative stress-induced
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apoptosis. In mouse embryonic fibroblasts (MEFs), H20 2 was able to induce LMP
prior

to

OMMP

during

apoptosis.

Outer

mitochondrial

membrane

permeabilization and subsequent apoptosis signaling, but not LMP, depended on
Noxa expression. The iron chelating agent DFO prevented H202-induced OMMP
and apoptosis by inhibiting LMP and subsequent increase in Noxa expression.
Therefore, LMP-induced Noxa expression is critical for OMMP and subsequent
activation

of

the

apoptosis

cascade
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during

oxidative

stress.

4.2. Materials and Methods
4.2.1. Reagents

DFO, etoposide, doxorubicin, actinomycin D, hydrogen peroxide (H202), acridine
orange (AO), and ferric ammonium citrate were purchased from Sigma (St.
Louis,

MO).

Staurosporine,

cisplatin,

and

carboplatin

were

from

Enzo

(Farmingdale, NY). Propidium iodide (PI), MitoTracker Green, MitoTracker Red,
and puromycin were from Invitrogen (Carlsbad, CA). Unless otherwise stated, all
reagents were dissolved in DMSO. DMEM, penicillinlstreptomycin (PIS), trypsin,
and L-glutamine were obtained from Mediatech (Manassas, VA), and FBS was
purchased from Gemini (Broderick, CA). The jetPRIME® transfection reagent
was from Polyplus-transfection (NYC, NY). The SensoLyte® Homogeneous
Rh110 caspase 3/7 assay kit was from AnaSpec (San Jose, CA). Antibodies
(Abs) used for western blot were anti-J3-actin mAb (Sigma), anti-Noxa pAb
(Imgenex; San Diego, CA), anti-cytochrome c (BD Pharmingen), peroxidaseconjugated goat anti-rabbit IgG (Thermo; Waltham, MA) and peroxidaseconjugated goat anti-mouse IgG (Thermo).

4.2.2. Cell lines and cell culture

MEFs deficient in the expression of the anti-apoptotic Bcl-2 protein BcI-XL (BcI-xKO) and their wild-type counterparts were used. Noxa-KO MEFs and their wildtype counterparts were provided by Professor Andreas Strasser (Walter and
Eliza Hall Institute of Medical Research, Parkville, VIC Australia). All MEFs were
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grown and maintained in DMEM supplemented with 10% FBS and 100 unitslml
of penicillin and 100 I-Ig/ml of streptomycin.

The bulk populations of the human colon cancer cell lines (HCT116) stably
expressing Noxa shRNA or the control luciferase shRNA were provided by Dr.
Onno Kranenberg (University Medical Center Utrecht; Utrecht, Netherlands). The
limited dilution method was used to obtain single clones, and Noxa expression
was examined by western blot. The HCT116 cells were grown and maintained in
DMEM supplemented with 5% FBS, 100 unitslml of penicillin, 100 I-Ig/ml of
streptomycin, 2 mM L-glutamine and 0.5 I-Ig/ml of puromycin. Cells were all
cultured in a 5% C02 humidified incubator at 37 cC.

4.2.3. Plasmid construction and retrovirus production
Murine Noxa cDNA was subcloned into the retroviral expression vector pBABEIRES-EGFP with the marker protein enhanced green fluorescence protein
(EFGP) expressed from an internal ribosomal entry site (IRES) as described
previously [151]. For retrovirus production, the human embryonic kidney (HEK)293T cells were transfected with the plasmid pBABE-mNoxa-IRES-EGFP or the
empty vector and the helper plasm ids pUVMC and pMDG2.0 using the
jetPRIME® transfection reagent. Retroviral supernatant was collected 48-72
hours after transfection and supplemented with 10 Ilglml polybrene to increase
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infection efficiency. Retrovirus expressing murine Noxa or GFP-only was used to
infect MEFs and cell viability was determined at the indicated time.

4.2.4. Cell viability
The propidium iodide (PI) exclusion method was used to determine cell viability.
Cells were plated in 48-well tissue culture plates at the density of 1 x 104 cells
per well 24 hours before exposure to death stimuli. Cells were pre-incubated with
or without 1 mM of the high-affinity iron chelator DFO for two hours. Cells were
then washed twice with fresh medium before exposure to the respective death
stimuli. At the indicated time, cells were collected in the presence of 1.0 /lg/ml of
PI and the percentage of live cells was measured using a flow cytometry analysis
(FACScalibur, Beckon Dickinson; San Jose, CA) as described previously [103].
Cell viability of treated cells was calculated as the percentage of the viability of
the untreated cells.

4.2.5. Caspase 3/7 activity
Approximately 5 x 103 MEFs were cultured in white-walled 96-well tissue culture
plates for 24 hours. MEFs were pre-incubated with or without 1 mM DFO for two
hours, washed twice with fresh medium before an exposure to the respective
death stimuli. MEFs were treated with H202 or actinomycin D for 7 hours,
exposed with etoposide, staurosporine, or doxorubicin for 12 hours, or infected
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with the retroviral supernatant expressing Noxa for 14 hours. Caspase 3/7
activity was determined using the Sensolyte® Homogeneous R 110 Caspase 3/7
Assay Kit (AnaSpec) according to the manufacturer's protocol. Caspase 3/7
activity of treated or infected cells was normalized to that of untreated controls.
The results were presented as relative fluorescence units per minute (RFUs/min).

4.2.6. Western blot analysis
Equal amounts of proteins (30 j.Jg) were separated on a 4-12% Bis-Tris gel (BioRad; Hercules, CA) and transferred onto PVDF membrane (Millipore; Billerica,
MA). The membrane was incubated with the appropriate primary or secondary
antibodies either overnight at 4°C or at room temperature for 3 hours in 1X
phosphate-buffered saline (PBS) containing 5% (w/v) nonfat dry milk (Bio-Rad)
and 0.2% (v/v) Tween 20. Protein levels were detected using the enhanced
chemiluminescent detection system (Pierce, Rockford, IL).

4.2.7. Microarray analysis
MEFs were pre-incubated with or without 1 mM DFO for 2 hours, washed twice
with fresh medium before a treatment with either 0.4 mM H202 for 6 hours or 0.3
mM iron ammonium citrate for 24 hours. Total RNA was acquired using the
RNeasy kit (Qiagen; Germantown, MD) according to the manufacturer's
instructions. RNA concentrations were determined with a NanoDrop 8000
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Spectrophotometer (Thermo), and the quality of total RNA was evaluated by a
2100 Bioanalyzer (Agilent; Santa Clara, CA). Global mRNA level alterations were
determined using the GeneChip Mouse Gene 1.0 ST Array for H20 2 experiments
or GeneChip Mouse Genome 430 2.0 Array for ferric ammonium citrate
experiments (Affymetrix; Santa Clara, CA).

4.2.8. Quantitative real time Polymerase Chain Reaction (qPCR)
Total RNA was extracted using the RNeasy kit (Qiagen) and its concentration
was measured using a NanoDrop 8000 Spectrophotometer (Thermo).
amounts (1

~g)

Equal

of total RNA were reverse transcribed. The TaqMan 20x probes

for murine and human Noxa (Applied Biosystems; Carlsbad, California) were
used to determine Noxa mRNA expression levels in MEFs and HCT116 cells
respectively. In MEFs tubulin was used as the endogenous control, whereas
actin served as the endogenous control in human HCT116 cells.

4.2.9. Lysosomal membrane stability
The Iysosomotropic base acridine orange (AO) was used to determine lysosomal
membrane

stability during

H202-induced

apoptosis.

Two

complementary

experiments were carried out to measure lysosomal membrane stability by
assessing changes in either green fluorescence (AO relocation method) or red
fluorescence (AO uptake method) upon an exposure to H202 [143]. In both
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cases, wild-type and Noxa-KO MEFs were plated in 48-well tissue culture plates
at a density of 2 x 104 per well and cultured for 24 hours. For AO relocation
experiments, the increase in green fluorescence was evaluated to detect early or
minor changes in lysosomal membrane stability. MEFs were pre-incubated with
or without 1 mM DFO for 2 hours, washed twice with fresh medium, before an
exposure to 5 llg/ml of AO for 30 minutes. MEFs were then treated with 0.4 mM
H202 for the indicated time, and changes in green fluorescence were determined
by flow cytometry (FACScalibur,

FL 1 channel). AO uptake experiments

measured changes in red fluorescence to detect severe or late lysosomal
membrane damage. Here, MEFs were pre-treated with or without 1 mM DFO for
2 hours, rinsed twice with fresh medium, followed by an exposure to 0.4 mM
H202 for one hour. MEFs were then returned to normal culture conditions by
washing and replacing with fresh medium. At the indicated time, cells were
treated with 5 llg/ml of AO for 15 minutes, and flow cytometry analysis was used
to measure changes in red fluorescence (FACScalibur, FL3 channel).

4.2.10. Mitochondrial membrane potential

The mitochondrion-selective probes MitoTracker Green and MitoTracker Red
were used to determine changes in mitochondrial membrane potential. Wild-type
and Noxa-KO MEFs were plated in 48-well tissue culture plates at a density of 2
x 104 and cultured for 24 hours. Following a treatment with 0.4 mM H202 for the
indicated time, MEFs were then incubated with 200 nM MitoTracker Green or
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200 nM MitoTracker Red for 1 hour. Green and red fluorescence of collected
MEFs were analyzed using a flow cytometer (FACScalibur).

Mitochondrial

membrane potential was shown as the ratio of fluorescence intensity of
mitochondrial

potential-sensitive

MitoTracker

Red

(FL3

channel)

and

mitochondrial potential-independent MitoTracker Green (FL 1 channel).

4.2.11. Statistical analysis

All experiments were performed in triplicate at least three times. Results are
presented as mean ± standard deviation. Statistical analysis was performed
using the two-way ANOVA and the student's two tail t-test. A P value < 0.05 was
considered significant.
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4.3. Results
4.3.1. Oxidative stress-induced LMP is independent of Noxa expression.
In the Iysosomes, the oxidative stress inducer H202 interacts with iron in a redox
reaction to produce highly reactive hydroxyl radicals, which in turn cause LMP
and subsequent apoptosis [152-154]. Our previous studies have shown that the
elevated expression of the pro-apoptotic BH3-only Bcl-2 protein Noxa mediates
apoptosis triggered by H202 [151]. To explore further the important role of Noxa
expression in H202-induced apoptosis, we first examined whether Noxa
expression influenced H202-induced LMP using MEFs deficient in Noxa
expression (Noxa-KO) and their wild-type counterparts. The Iysosomotropic base
acridine

orange

(AO)

is

a

metachromatic fluorochrome

exhibiting

red

fluorescence when it is highly concentrated in intact Iysosomes, but emitting
green fluorescence when its concentration is low as observed in Iysosomes with
disrupted membrane integrity [124]. Two complementary approaches (AO
relocation and AO uptake) were used to examine lysosomal membrane stability
following H20 2 exposure. In AO relocation experiments, wild-type and Noxa-KO
MEFs were first incubated with 5 Ilg/ml of AO before exposure to 0.4 mM H20 2.
Thirty minutes post H202 treatment, there was a significant increase in green
fluorescence levels in wild-type and Noxa-KO MEFs, indicating minor damage to
lysosomal membrane integrity (Figure 4.1A). Importantly, the green fluorescence
intensity increase was similar in both cell lines, providing evidence that Noxa
expression did not influence H202-induced LMP despite its critical role in
mediating apoptotic signaling pathways. Furthermore, pre-incubating cells with 1
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mM of the highly potent iron chelator desferrioxamine (OFO) prevented LMP
independent of Noxa expression (Figure 4.1A).

To assess further the effects of Noxa expression on late lysosomal membrane
rupture, we carried out AO uptake experiments to estimate the percentage of
"pale" cells (cells with damaged Iysosomes). Following one hour-treatment with
H202, MEFs were cultured in normal growth medium, and the intensity of red
fluorescence emitted from AO inside cells was determined. Twenty four hours
later, the fraction of cells displaying "pale" cell phenotype markedly increased in
both wild-type and Noxa-KO MEFs, indicating late lysosomal membrane rupture
(Figure 4.1 B). Furthermore, the increase in late lysosomal membrane rupture
was abolished by pre-incubation with OFO. Consistent with the results of AO
relocation experiments (Figure 4.1A), H20 2 was able to induce comparable late
lysosomal membrane rupture in wild-type and Noxa-KO MEFs (Figure 4.1C).
Overall, these results indicate that H202 induces LMP independent of Noxa
expression, suggesting that Noxa mediates H202-triggered apoptosis at a phase
downstream of destruction of lysosomal membrane integrity.
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Figure 4.1. H202 induced Noxa-independent LMP. (A) Wild-type and Noxa-KO
MEFs were pre-incubated with or without 1 mM DFO for 2 hours, followed
by an exposure to 5 Ilg/ml acridine orange (AO) for 15 minutes. MEFs
were then treated with 0.4 mM H202 for the indicated time. Green
fluorescence emitted from AO inside cells was determined using flow
cytometry analysis. Data represent mean ± standard deviation of three
independent experiments performed in triplicates. (8) Following preincubation with or without 1 mM DFO for 2 hours, wild-type and Noxa-KO
MEFs were exposed to 0.4 mM H202 for 1 hour. MEFs were then cultured
in normal growth medium for 24 hours. MEFs deficient in intact Iysosomes
('pale' cells) were analyzed by flow cytometry. Data represent one of three
independent experiments. (C) The summary of the experimental results
shown in (8). The data are shown as mean ± standard deviation of three
independent experiments performed in triplicates.
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4.3.2. Noxa-dependent outer mitochondrial membrane permeabilization
(OMMP) occurs downstream of LMP during H202-induced apoptosis.
The OMMP and subsequent release of apoptogenic proteins such as cytochrome
c from mitochondria to the cytosol are the molecular hallmarks of apoptosis [39].
To determine the temporal relation between MOMP and LMP during H202induced apoptosis, we first examined the amounts of cytochrome c released into
the cytosol as an indicator of OMMP. To this purpose, both wild-type and NoxaKO MEFs were treated with H202, and the presence of cytochrome c in cytosolic
fractions was determined by western blot (Figure 4.2A). The levels of cytochrome
c in cytosolic fractions of Noxa-KO MEFs were largely unchanged upon 24-hour
H202 exposure, indicating very little OMMP.

However, the amounts of

cytochrome c were notably higher in cytosolic fractions of wild-type cells after 14hour H202 treatment, consistent with previously reported role of NOXA in
mediating H202-indcued apoptosis. As LMP was observed 30 minutes following
H202 treatment in both wild-type and Noxa-KO MEF cells (Figure 4.1A), these
results provide evidence that MOMP occurs following LMP during oxidative
stress-induced apoptosis.

As a direct result of increased OMMP, mitochondrial membrane potential
decreases in cells undergoing apoptosis, which has been commonly used as an
indicator of OMMP [155]. To determine the temporal relation between OMMP
and LMP during H202-induced apoptosis, we measured mitochondrial membrane
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potential at different time following an exposure to H202 using the mitochondrial
potential-sensitive probe MitoTracker Red and the mitochondrial potentialindependent probe MitoTracker Green. An exposure to H 20 2 led to a timedependent decrease in mitochondrial membrane potential in both wild-type and
Noxa-KO MEFs, but mitochondrial membrane potential dissipated much faster in
wild-type MEFs compared with Noxa-KO MEFs (Figure 4.28).

In contrast to the occurrence of LMP 30 minutes following H202 treatment (Figure
4.18), no changes in mitochondrial membrane potential were detected in either
MEF cell line within one hour of H202 exposure. Even after 6 hours of H202
exposure, mitochondrial membrane potential was reduced about 30% in wildtype MEFs, whereas mitochondria in Noxa-KO MEFs were still intact. Twentyfour hours of treatment with H202 almost completely disrupted mitochondrial
membrane integrity in wild-type MEFs, but there was only about 25% reduction in
mitochondrial membrane potential in Noxa-KO MEFs. Since Noxa-KO MEFs
were more resistant to H202-induced OMMP, Noxa expression was important for
OMMP induction, which is consistent with previous studies about the role of Noxa
in H20 2-induced apoptosis [151]. Importantly, stabilizing lysosomal membranes
by pre-incubation with DFO significantly inhibited H202-induced mitochondrial
membrane potential reduction (Figure 4.2C). Thus, it is likely that mitochondrial
membrane rupture occurs downstream of LMP in cells undergoing oxidative
stress.
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Figure 4.2. Mitochondria membrane permeabilization is dependent on Noxa
expression. (A) Wild-type and Noxa-KO MEF cells were treated with 0.4
mM H202.

The amounts of cytochrome c in cytosolic fractions at the

indicated time points were detected by western blot.

(8) Following an

exposure with 0.4 mM H202 for the indicated time, wild-type and Noxa-KO
MEFs were incubated with 200 nM Mitotracker Red or 200 nM Mitotracker
Green for 1 hour. Flow cytometer was used to measure red and green
fluorescence intensity of MEFs. Mitochondrial membrane potential was
calculated as the ratio of red to green fluorescence intensities and
normalized. Experiments were performed in triplicates and mean ±
standard deviation of three independent experiments is shown. (C) Wildtype and Noxa-KO MEFs were pre-incubated with or without 1 mM DFO
for two hours before a treatment with 0.4 mM H2 0 2 for 24 hours. Changes
in

red

and

green

fluorescence

intensities were

determined

and

mitochondrial membrane potential was calculated as shown in (A). Data
are presented as mean ± standard deviation of three independent
experiments performed in triplicate.
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4.3.3. LMP is essential for Noxa-mediated apoptosis in H202-treated cells.

Since Noxa expression is critical for OMMP (Figure 4.2) but dispensable for LMP
(Figure 4.1), we investigated the importance of LMP for Noxa-mediated
apoptosis in H202-exposed cells. As expected, wild-type MEFs were more
susceptible to H202 treatment compared with their Noxa-KO counterparts (Figure
4.3A). Upon H202 exposure, Noxa-mediated apoptosis was abolished in cells
pretreated with DFO, providing evidence that the impact of LMP on cellular
responses to H202 depends on Noxa expression (Figure 4.3A). In addition,
caspase 3/7 activity was measured following an exposure to H202. While there
was more caspase 3/7 activity in wild-type MEFs than Noxa-KO MEFs, preincubation with DFO significantly reduced caspase 3/7 activity in both cell lines
(Figure 4.38). The correlation between caspase 3/7 activity and the level of cell
death indicates that LMP exerts its influence on H202-induced apoptosis through
endogenous Noxa.

To further confirm the role of Noxa expression in H20 2-triggered LMP and
subsequent apoptosis, Noxa expression in human colon cancer HCT116 cells
was stably reduced by shRNA (Figure 4.3C). HCT116 cells with normal or
reduced Noxa expression were exposed to H20 2 in the presence or absence of
DFO pre-incubation. Consistent with the studies with MEFs (Figure 4.3A), the
reduction of Noxa expression rendered HCT116 cells more resistant to H202
treatment, validating the critical role of Noxa in H20 2-triggered apoptosis.
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Furthermore, OFO pre-incubation abolished H202 cytotoxicity in HCT116 cells
with normal Noxa expression (Figure 4.30), providing more evidence that the
pro-apoptotic effects of Noxa on H202-induced apoptosis depends on LMP.
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Figure 4.3. Stabilizing lysosomal membrane by OFO inhibits Noxadependent apoptosis induced by H202. (A) Wild-type and Noxa-KO
MEFs were pre-incubated with or without 1 mM DFO for 2 hours. MEFs
were then treated with 0.4 mM H202 for the indicated time, and cell
viability was determined using a flow cytometry analysis. Data are
presented as mean ± standard deviation of three different experiments
that were carried out in triplicates. (8) Caspase 3/7 activity was measured
after 2 hour-incubation with or without DFO followed by a treatment with
0.4 mM H202 for 6 hours. Data shown are mean ± standard deviation of
three independent experiments performed in triplicates.

(C)

Noxa

expression of was reduced in HCT116 cells by a small hairpin RNA
(shRNA). The expression levels of Noxa were determined by western blot.
(0) The HCT116 cells with normal (shLuc) or reduced (shNoxa) Noxa

expression were incubated with or without DFO for 2 hours before an
exposure with 0.4 mM H20 2 for the indicated time, and cell viability was
measured. Mean ± standard deviation of three independent experiments is
presented.
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4.3.4. LMP is not involved in the regulation of some apoptosis paradigms
To examine whether the induction of LMP is also critical in other apoptosis
paradigms, wild-type MEFs were treated with death stimuli that have diverse
mechanisms of action, including the topoisomerase inhibitor etoposide, the DNA
intercalating agent doxorubicin, the transcriptional inhibitor actinomycin 0, and
the protein kinase inhibitor staurosporine. MEFs were pretreated with DFO for 2
hours followed by a treatment with the respective death stimuli. Pre-incubation
with DFO failed to prevent apoptosis induced by any of the four death stimuli
examined (Figure 4.4A), indicating that LMP did not occur or was not involved in
apoptosis signaling induced by any of these agents. These results demonstrate a
specific role of LMP in regulating oxidative stress-induced apoptosis in MEFs.
This was strengthened further by the observation that caspase 3/7 activity
detected in MEFs treated with different death stimuli closely correlated with the
cell viability measurements, and pre-incubation with DFO did not affect caspase
3/7 activity (Figure 4.48).

To determine further the relevance of LMP in apoptotic signaling pathways
initiated by chemotherapeutic drugs, human HCT116 cells with different Noxa
expression levels were treated with cisplatin or carboplatin, two anti-cancer
agents whose cytotoxicity has also been shown to depend on Noxa expression.
HCT116 cells expressing normal levels of Noxa were more sensitive to both
agents compared with their Noxa knockdown counterparts (Figure 4.4C).
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Importantly, DFO failed to antagonize the pro-apoptotic activity of both drugs,
indicating that LMP is irrelevant in apoptotic signaling triggered by cisplatin or
related compounds (Figure 4C).
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Figure 4.4. DFO fails to prevent apoptosis induced by other apoptotic
stimuli. (A) Wild-type MEFs were incubated with or without 1 mM DFO for
2 hours, then treated with etoposide
actinomycin D (0.2

~g/ml),

(5~M),

doxorubicin (1

~M),

or staurosporine (5 nM) for the indicated time.

Cell viability was determined using flow cytometry. Mean ± standard
deviation of three independent experiments that were performed in
triplicates is presented. (8) Caspase 3/7 activity was measured following
12 hour-treatment with etoposide, doxorubicin, or staurosporine, or 9 hourtreatment with actinomycin D using a fluorometric assay. Data are
presented

as

mean

± standard

deviation

of three

independent

experiments performed in triplicate. (C) The human HCT116 cells (shLuc
and shNoxa) were pre-incubated with or without 1 mM DFO for 2 hours
before a treatment with cisplatin (50 IlM) or carboplatin (200 IlM). Cell
viability was then measured using the PI exclusion method. Data are
shown as mean ± standard deviation of three independent experiments
carried out three times.
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4.3.5. LMP is not involved in apoptosis induced by ectopic Noxa
expression.

As our studies have shown that stabilizing lysosomal membrane by DFO
prevents Noxa-dependent apoptotic signaling triggered by H202 (Figure 4.3), it is
possible that DFO directly antagonizes pro-apoptotic activities of Noxa. To
explore this possibility, we examined whether DFO could affect the pro-apoptotic
activities of ectopically expressed Noxa. As Noxa expression displays much
higher killing activities in MEFs deficient in 8c1-XL expression (8c1-x-KO)
compared with wild-type MEFs [151], both 8cl-x-KO and wild-type MEFs were
pre-incubated with or without DFO before infection with retrovirus expressing
Noxa. Unlike its activity on H202-induced apoptosis, DFO failed to prevent
apoptosis induced by ectopic Noxa expression in both wild-type and 8c1-x-KO
MEFs (Figure 4.5A). Caspase 3/7 activity measurments further validated the
inability of DFO to antagonize pro-apoptotic activities of ectopic Noxa expression,
indicating that DFO inhibits H202-induced apoptosis at a step upstream of Noxa
expression (Figure 4.58)
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4.3.6. H202-induced increase in Noxa expression is mediated by LMP.

As the induction of Noxa expression is critical for H202-induced apoptosis, we
systematically examined the effect of LMP on the expression of pro-apoptotic
BH3-only BcI-2 proteins in MEFs using microarray. While DFO itself did not
significantly affect gene expression of BH3-only Bcl-2 proteins, stabilizing
lysosomal membranes by DFO was able to abolish the effects of H202 on Noxa
mRNA expression levels (Figure 4.6A). Quantitative real-time polymerase chain
reaction (qPCR) experiments were also carried out to confirm that LMP mediates
Noxa expression increase in oxidative stress-induced apoptosis (Figure 4.6B).
Our studies have shown that Noxa expression mediates apoptosis-induced by
H202 or cisplatin, but stabilizing lysosomal membrane by DFO was only able to
prevent H202-induced but not cisplatin-triggered apoptosis (Figure 4.3).

To explore the distinct roles of LMP in different Noxa-dependent apoptosis
paradigms, we examined the effect of DFO on Noxa expression induced by H20 2
and cisplatin respectively in HCT116 cells (Figure 4.6C). DFO abolished H20 2caused Noxa mRNA induction, but failed to prevent cisplatin-induced increase in
Noxa mRNA expression, correlating with the inability of DFO to inhibit apoptosis
induced by cisplatin. The results of these experiments further validate the unique
role of LMP-induced Noxa expression induction in apoptosis caused by oxidative
stress.
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Figure 4.6. H202-induced increase in Noxa expression is specifically
mediated by LMP. (A) Wild-type MEFs were pre-incubated with or
without DFO for 2 hours, before treated with 0.4 mM H202 for 6 hours.
Total RNA was extracted and microarray analysis was carried out to
determine global changes in mRNA expression levels upon H202
treatment. (8) A qPCR analysis was performed using the total RNA
generated in (A) to validate the results generated by microarray analysis.
Data are presented as mean ± standard deviation of three independent
experiments performed in triplicates. (C) DFO prevented Noxa expression
increase induced by H20 2 but not cisplatin. After pre-incubation with or
without DFO for 2 hours, HCT116 cells (shLuc) were treated with either
0.4 mM H202 for 6 hours or 50 IlM cisplatin for 14 hours. Total RNA was

collected and a qPCR analysis was performed to determine Noxa mRNA
levels. Mean ± standard deviation of three independent experiments is
presented. **P<0.01; ***P<0.001; Student's unpaired t test. ns, no
significance.
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4.3.7. Iron overload specifically enhances Noxa expression

Lysosomal labile iron has been shown to translocate to the nucleus and cause
oxidative damage to DNA during oxidative stress-induced apoptosis [134-136].
Therefore, it is possible that redox active iron released into the cytosol might be
responsible for LMP-induced Noxa expression. To examine this possibility, the
effects of exogenous iron on changes in global mRNA expression were
determined by microarray experiments performed in wild-type MEFs treated with
ferric ammonium citrate. Upon iron exposure, the most prominent increase in
gene expression in the BH3-only BcI-2 protein family was Noxa, which was
similar to the expression profile of H202 exposure (Figure 4.7 A). The degree of
Noxa induction in iron-loaded cells was modest compared with that observed in
cells exposed to H202 (Figure 4.6A), which could be attributed to the different
array types used in these experiments. DFO was able to prevent iron-induced
increase in Noxa expression but had little effect on the mRNA expression levels
of other BH3-only Bcl-2 proteins.

The qPCR analyses further confirmed that

exogenous iron specifically induced Noxa mRNA expression level (Figure 4.7B).
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4.4. Discussion

Oxidative stress-triggered LMP is well documented, but the detailed mechanisms
through which LMP is coupled with OMMP and eventual apoptosis are still
unclear. Here we investigated the role of lysosomal membrane rupture in
regulating apoptosis caused by the oxidative stress inducer H202. Upon H202
exposure, the integrity of lysosomal membranes was disrupted independent of
endogenous Noxa, despite its essential role in apoptosis signaling. Noxadependent OMMP appeared to occur downstream of LMP. Stabilizing lysosomal
membranes specifically inhibited Noxa expression increase and Noxa-mediated
apoptosis in H202-treated cells. Overall, our studies provide molecular evidence
that LMP modulates cellular responses to oxidative stress by regulating Noxa
expression.

The mechanisms of apoptosis signaling induced by LMP have been under
intensive study. It is generally believed that the rupture of lysosome membranes
releases hydrolytic enzymes normally resided inside Iysosomes into the cytosol,
which may in turn trigger apoptotic signaling by hydrolyzing their substrates
[149]. However, severe lysosomal membrane damage leads to a massive exodus
of lysosomal enzymes into the cytosol, indiscriminately digesting cellular
components, causing deleterious cytoplasmic acidification, and inducing necrosis
instead of apoptosis. The concentration of H202 examined in our studies induced
maximal apoptotic cell death but minimal necrosis in MEFs [151]. In this oxidative
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stress paradigm, the induction of OMMP and subsequent apoptosis depended on
Noxa expression (Figures 4.2 and 4.3). On the contrary, both early and late
lysosomal membrane rupture occurred at same rates in wild-type and Noxa-KO
MEFs (Figure 4.1), suggesting that hydrolytic activities of discharged lysosomal
enzymes are unlikely to be responsible for initiating more prominent apoptotic
cascades in Noxa-expressing cells. It is conceivable that partial lysosomal
damage under the conditions in our studies only promotes limited release of
lysosomal enzymes whose concentrations in the cytosol are not high enough to
trigger apoptosis by themselves. Instead, the induction of Noxa expression by
LMP is responsible for oxidative stress-induced apoptosis in MEFs. Thus, the
strength of oxidative insults and the cell type could determine how apoptotic
signaling is activated in response to oxidative insults.

Recent studies have demonstrated that both anti- and pro-apoptotic BcI-2
proteins are involved in apoptotic signaling initiated by LMP. Overexpressing
anti-apoptotic BcI-2 in murine histiocytic lymphoma cells suppresses oxidantinduced apoptosis by stabilizing lysosomal membranes and the phosphorylation
of BcI-2 is required for this activity [124, 125]. In multiple apoptosis paradigms,
Bax has been shown to translocate to Iysosomes to mediate LMP, probably by
oligomerizing and forming permeation channels on lysosomal membranes [156,
157]. Upon TNFa treatment, tBid is generated by caspase 8 and induces Biddependent lysosomal membrane rupture, leading to discharge of the lysosomal
protease cathepsin B into the cytosol and eventual apoptosis [158, 159]. Given
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that Noxa expression is dispensable for LMP induction in response to oxidative
stress, Noxa likely functions at the mitochondrial level to mediate apoptosis,
which is supported by our evidence about temporal relation of OMMP and LMP in
H202-treated cells (Figures 4.1 and 4.2).

Although originally identified as a primary p53-response protein, Noxa expression
increases

in

response

to

diverse

apoptotic

stimuli,

including

some

chemotherapeutic agents [160]. Our studies indicate that during H202-induced
apoptosis LMP induced Noxa expression increases in both MEFs and HCT116
cells (Figure 4.6). This induction of Noxa is unlikely caused by p53 activation,
since MEFs examined in our studies have been immortalized by SV40 T antigen,
a known p53 deactivator [151]. In contrast, the increase in Noxa expression in
cells exposed to cisplatin or cisplatin-related compounds could depend on p53
[158, 161]. Thus, the different effects of stabilizing lysosomal membranes by
DFO on cisplatin- or H202-induced apoptosis could be attributed to the underlying
mechanisms of Noxa induction in these two apoptosis paradigms.

Lysosomes contain abundant labile iron, and the rupture of lysosomal membrane
leads to redox-active iron translocation to the nucleus during oxidative stress
[134, 135]. I reasoned that lysosomal redox-active iron might be responsible for
subsequent transcriptional responses to oxidative responses, particularly proapoptotic BcI-2 proteins. Indeed, the transcription profile of BH3-only Bcl-2
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proteins in cells loaded with exogenous iron recapitulated that of cells undergoing
oxidative stress (Figure 4.7), suggesting that LMP-triggered apoptosis signaling
is transduced into the nucleus to induce Noxa transcription via released
lysosomal redox-active iron. In support of this model, lysosomal redox-active iron
has been reported to generate oxidative damage to DNA [136] and Noxa is
known to be a DNA damage-responsive protein [160]. In summary, our studies
reveal a novel mechanism by which lysosomal membrane stability regulates
H20 2-induced apoptosis. Future research will focus on investigating the signaling
pathway, particularly the involvement of redox-active iron, in the induction of
Noxa expression.
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CHAPTER V

SUMMARYANDFUTUREPERSPECTNES
5.1. Summary and conclusions
Previous studies have shown that overexpression of the anti-apoptotic Bcl-2
protein BcI-XL prevents apoptosis initiated by diverse apoptotic stimuli. The exact
mechanism of how BcI-XL prevents apoptosis is still unclear and controversial. As
BcI-XL likely functions to modulate OMM integrity, overexpression of Bcl-XL could
relocate BcI-XL to non-physiological locations inside cells, leading to unexpected
biological

consequences.

Therefore,

studying

the activities of Bcl-XL at

endogenous levels will fill critical gaps in our understanding of the molecular and
biochemical mechanisms by which Bcl-XL regulates apoptosis.

Endogenous Bcl-XL has been demonstrated to localize in the mitochondria, the
ER, and the cytosol. I investigated the molecular functions of Bcl-XL exclusively
localized in a particular subcellular compartment on regulation of apoptosis and
Ca 2 + homeostasis using MEFs. The carboxyl-terminal transmembrane domain of
BcI-XL was deleted to confine Bcl-XL specifically to the cytosol. The carboxylterminus of BcI-XL was replaced with either the mitochondria targeting sequence
of the Listeria protein ActA or the ER targeting sequence of cytochrome bS (cbS),
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which targets Bcl-XL to the mitochondria or the ER respectively. Targeting BcI-XL
at the mitochondria but not at the ER prevented apoptosis induced by diverse
death stimuli to the degree observed in wild-type MEFs. However, expression of
ER-targeted Bcl-XL but not mitochondrially targeted BcI-xL was required to
modulate Ca 2+ homeostasis. Of importance, ER-targeted BcI-xL was able to
prptect cells against death stimuli in the presence of endogenous Bcl-XL. These
data indicate that mitochondrial BcI-xL can regulate apoptosis independently of
ER Bcl-XL and that when localized exclusively at the ER, BcI-XL impinges on Ca 2+
homeostasis but does not affect apoptosis unless Bcl-XL is present in additional
cellular compartments.

Next I investigated how endogenous BcI-xL regulates oxidative stress-induced
apoptosis. Oxidative stress has been known to induce both necrosis and
apoptosis dependent on the severity of the oxidative stress to cells. Mild to
moderate oxidative stress causes apoptosis whereas severe oxidative stress
triggers necrosis [93, 151]. The exact mechanism through which oxidative stress
inducers, including H20 2, promote apoptosis is unclear but recent evidence
suggests the involvement of the Bcl-2 proteins. Thus, I investigated how the
complex Bcl-2 protein network might regulate oxidative stress-induced apoptosis.
Using MEFs, I found out that endogenous BcI-XL prevented apoptosis initiated by
H202. Furthermore, the pro-apoptotic BH3-only Bcl-2 protein Noxa was required
for H202-induced apoptosis and was the only BH3-only BcI-2 protein whose proapoptotic activity was completely antagonized by endogenous BcI-XL. Upon H202
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treatment, Noxa mRNA displayed the greatest increase among BH3-only Bcl-2
proteins. Also, expression levels of the anti-apoptotic BcI-2 protein McI-1, the
primary binding target of Noxa, were greatly reduced in cells treated with H202 in
a Noxa-dependent fashion, and McI-1 overexpression prevent H20 2-induced
apoptosis. Overall, these studies reveal a signaling pathway in which H20 2
activates Noxa, leading to a decrease in McI-1 expression and subsequent cell
death in the absence of BcI-XL expression. Therefore, both anti-apoptotic and
pro-apoptotic BcI-2 proteins cooperate to regulate oxidative stress-induced
apoptosis.

Finally, I investigated the important role of lysosomal membrane permeabilization
(LMP) during oxidative stress-induced apoptosis. Previous studies have
implicated LMP in oxidative stress-induced apoptosis, but the exact role of LMP
in oxidative stress-triggered apoptotic cascade or how it is regulated by the BcI-2
protein network is not completely understood. Here, I determined the temporal
relation between LMP and OMMP using MEFs deficient in Noxa and their wildtype counterparts. Although Noxa expression was important for H202-triggered
OMMP and subsequent apoptosis, H202-induced LMP was independent of Noxa
expression. However, Noxa-dependent OMMP induction occurred downstream of
LMP. When the lysosomal membranes were stabilized by the iron chelating
agent DFO, H202-induced increase in Noxa expression and subsequent
apoptosis was prevented probably by inhibition of LMP. DFO prevented H202induced increase in Noxa expression but failed to prevent cisplatin-caused Noxa
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expression induction, indicating that LMP is unique for oxidative stress-triggered
apoptosis. Thus these studies reveal a novel signaling pathway for H20 2-induced
apoptosis, in which an increase in Noxa expression couples LMP with OMMP
and ultimate apoptosis.

5.2. Future perspectives
Further research will focus on investigating the signaling pathway, particularly
lysosomal redox-active iron, involved in the regulation of Noxa expression.
Because DNA damage causes increase in p53 proteins which in turn activates
Noxa expression, I will further explore the involvement of

H202

in DNA damage,

activation of p53 proteins, increase in Noxa expression and subsequent
apoptosis. I will also further elucidate the involvement of the crosstalk between
mitochondrial-localized and ER-Iocalized Bcl-XL in apoptosis regulation and Ca 2 +
homeostasis.
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APPENDIX
List of Abbreviations
ANOVA

Analysis of variance

AO

Acridine Orange

APAF-1

Apoptotic protease activating factor 1

ATF4

Activating transcription factor 4

Bad

BcI-2/Bcl-xL-associated agonist of cell death

Bcl-2

B cell lymphoma/leukemia-2

BH

BcI-2 Homology

Bid

BH3-interacting domain death agonist

Bik

BCI-2-interacting killer

Bim

BcI-2-interacting mediator of cell death

Bmf

Bcl-2-modifying factor

Bnip3

Bcl2/adenovirus E1 B-interacting protein 3

Ca 2+

Calcium (II) ions

CPA

Cyclopiazonic acid

DFO

Desferrioxamine

DISC

Death-inducing signaling complex

DMSO

Dimethyl sulfoxide

DKO

Double knock out

DMEM

Dulbecco's Modified Eagle Medium

EGFP

Enhanced green fluorescent protein

E. coli

Escherichia coli
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ER

Endoplasmic reticulum

FADD

Fas-associated death domain

FBS

Fetal bovine serum

H20 2

Hydrogen peroxide

HBSS

Hanks balanced salt solution

Hrk

Activator of apoptosis harakiri

lAPs

Inhibitors of apoptosis proteins

ICM

Intracellular-like medium

IMS

Inter membrane space

InsP3R

Inositol trisphosphate receptor

IP

Immuno-precipitation

IRES

Internal ribosomal entry site

KO

Knock out

LMP

Lysosomal membrane permeabilization

mAb

Monoclonal antibodies

Mcl-1

Myeloid cell leukemia sequence 1

MEFs

Mouse embryonic fibroblasts

mRNA

messenger Ribonucleic acid

Nix

Bcl2/adenovirus E1 B-interacting protein like-3

OMMP

Outer mitochondrial membrane permeabilization

pAb

Polyclonal antibodies

PBS

Phosphate buffer saline

PCR

Polymerase chain reaction

PI

Propidium iodide

PKA

Protein kinase A

PP2A

Protein phosphatase 2A

PIS

PenicillinlStreptomycin
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PS

Phosphatidylserine

Puma

p53 up-regulated modulator of apoptosis

qPCR

quantitative real time polymerase chain reaction

REs

Restriction endonucleases

RFUs

Relative fluorescent units

Rt-PCR

Reverse transcriptase polymerase chain reaction

ROS

Reactive oxygen species

SAPKlJNK Stress-activated/c Jun N-terminal kinase
SERCA

Sarco/endoplasmic reticulum Ca 2+-ATPase

siRNA

small interference- Ribonucleic acid

tBid

Truncated Bid

TM

Transmembrane

TNF

Tumor necrosis factor

TNFR

Tumor necrosis factor receptors

VDAC2

Voltage-dependent anion channel 2

WT

Wild type
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